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ABSTRACT
To fabricate living cell-based immunological sensors, we have examined two PEO-based
biomaterials that can be patterned to generate cellular array templates: poly(allylamine)-g-
poly(ethylene glycol) graft-copolymer and poly(ethylene glycol) dimethacrylate hydrogel.
Poly(allylamine)-g-poly(ethylene glycol) polycation graft-copolymers were designed,
synthesized, and characterized in order to combine bio-functionality with patternability on
charged polyelectrolyte multilayer surfaces. Polymer-on-polymer stamping (POPS) techniques
were used to create micron scale patterned regions on negatively charged multilayer surfaces via
direct stamping of these graft copolymers. The long PEG side chains effectively resisted
adsorption of antibodies or other proteins, and created a bio-inert area when patterned by POPS.
On the other hand, desired proteins can be covalently attached to the graft copolymer by
introducing proper coupling agents. Arrays of proteins were produced by either simple
adsorption or coupling of proteins onto the graft copolymer patterned surfaces. The protein
arrays were utilized as templates in fabricating cellular arrays of non-adherent B cells.
Poly(ethylene glycol) dimethacrylate hydrogel precursors were photopolymerized into 3D
rmicrowell array templates via micromolding. After the floors of microwells were decorated with
antibodies, hydrogel microwell array templates were employed in fabrication of cellular arrays.
The topology of microwells facilitates the positioning of cells inside microwells and improves
the binding stability of cells with protection from mechanical agitations.
T cell arrays fabricated on hydrogel microwell array templates were tested as living cell-
based immunological sensors. B cells were settled uniformly on T cell arrays to establish
contacts between B and T cells over a large area. A level of T cell activation by target peptides
were quantified using calcium sensitive fura dyes. A large set of individual T cell response data
was acquired from a single T cell array and utilized to obtain average dose-response behavior of
T cells. Average T cell responses were suitable as quantitative signal of a living cell-based
immunological sensor. In addition, a potential application of T cell arrays in high throughput
assay of individual T cell responses was investigated. Analysis of calcium oscillation frequency
of individual T cells revealed that there is no clear correlation of calcium oscillation frequency
with target peptide dose in this experiment.
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1 Introduction
1. Objective of study
The current trend of academic crossover between different scientific fields is well exemplified
by recent achievements made in the area of tissue engineering; knowledge in material science,
chemistry, etc. has been synergistically combined with biological understanding to create this
new subject. Encouraged by this successful example, one may ask: instead of replacing natural
parts, i.e. tissues, with artificial or synthetic ones as in tissue engineering cases, is it also possible
to substitute living organisms for man-made device components?
The overall goal of this thesis is to address that question with a model system, an
immunological sensor based on living cells. An immunological sensor is a sensor that can detect
the presence of certain pathogens and also that can measure the contamination or infection level
by those pathogens in a test sample. The purpose of this research, in other words, is to fabricate
an immunological sensor device (chip) that employs live cells as its key sensing components. To
realize this goal, we created live T cell arrays and established B cell - T cell contacts uniformly
across the chip surface. We then analyzed responses of this system to model peptide analytes.
A majority of biosensors that have been investigated and developed utilize bio-molecular
entities, such as enzymes and antibodies, to detect analytes. From the view point of signals that
are actually measured, these biosensors can be divided into largely three types: electrochemical
(or electrical) 1-6, optical 7 TM", and mechanical' 2 '15 biosensors. Electrochemical biosensors can be
further classified into potentiometric, l amperometric,3' 4' 6 and impedometric2 5 biosensors
depending on which electric parameter is measured. Optical biosensors rely on measuring
fluorescence, 7 surface plasmon resonance, °'0 " or a lightmode spectrum 8'9 using optical
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waveguide systems. Mechanical biosensors detect vibrational frequency changes using a
piezoelectric quartz crystal microbalance or swelling of a bio-molecule embedded matrix using a
pressure transducer. 1 5
In spite of the diversity of sensing signals, most of these biosensors are essentially based on
either a redox reaction in an enzyme/substrate interaction or a bio-specific (or, rarely, non-
specific) binding of analytes and sensor components (bio-molecules). Enzymes such as L-amino
acid oxidase, 6 polyphenol oxidase, 3 and L-lactate dehydrogenase, 4 process their substrates to
generate byproducts, such as protons, H202, etc., that can transduce electric current. Most
amperometric biosensors are based on enzymes of this type. Bio-specific binding, such as
antibody/antigen interactions and DNA base pairing, assure specificity of biosensors and provide
a broader basis for various types of biosensors because electrical, optical, and mechanical
characteristics of the system change when binding, either specific or non-specific, occurs. Many
biosensors make use of differences in conductivity, impedence, refractive index, mass, etc.
between the on- and off-states of these binding events.
It is often challenging to compare the sensitivity of one type of biosensors with another
because there are limited examples of different biosensors that share a target analyte. However,
amperometric biosensors may have an advantage in sensitivity relative to other biosensor types
because any kind of signal, either optical or mechanical, should eventually be converted to an
electric signal. For example, an amperometric lactate dehyrogenase (LDH) biosensor has been
reported to have a sensitivity 50 units/L.4 However, as mentioned above, amperometric
biosensors require the use of a certain type of enzymes.
Recently, there have been some efforts to incorporate live cells instead of small bio-molecules
in biosensors. '6 2 1 Some researchers have cultured cells on microelectronic circuitry to measure
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impedence change of cells, 18 for example at death, or analyze small heat exchange
accompanying mast cell activation by antigen. 6 Whereas these hybrid approaches have
succeeded in producing only yes-or-no type signals, quantitative responses have been obtained in
a simple bulk assay of antigens utilizing live B cells that had been genetically engineered to
express a Ca2+-sensitive bioluminescent protein as well as membrane-bound antibodies specific
to target viruses.2 2 When B cells were activated by binding of viruses to antibodies,
bioluminescent proteins emitted light with intensity correlated to dose of viruses. However, like
any other antibody based system, this approach is vulnerable to mutation of virus surface
proteins that are the targets of antibodies.
The model system investigated in our study extends the concept of the live B cell-based
immunological assay. We have employed T cells in 2 dimensional cellular arrays together with
B cells as antigen presenting cells (APCs). Since microbes are processed in APCs and T cells
probe the fragments of microbes bound to major histocompatibility complex (MHC) molecules
on the APC membrane,23 T cell-based sensors have the potential advantage of detecting non-
mutatable core peptide sequences from pathogens, making it more difficult to 'fool' the sensor
by mutating the structure of a target pathogen.
The model system takes advantages of effectiveness and efficiency that nature has created in
immune system through evolution. Because T cells sensitively respond only to specific targets,
sensitivity and specificity requirements for a sensor are inherently satisfied by simply utilizing T
cells as a sensing; component. An immune sensor can be built by controlling microenvironments
to ensure reliable and reproducible T cell activation. Activation of a T cell by specific antigens
on an antigen presenting cell induces an increase in cytosolic Ca2+ level through a series of signal
12
transduction events. The fluorescence intensity of calcium sensitive dyes characterizing
intracellular Ca2+ levels plays a role as the optical signal that is captured for sensing.
Realization of the goals of this work required new material interfaces capable of controlling T
cell interactions with substrates, proteins, and/or other cells. Also, these materials needed to be
compatible with various patterning techniques in micron scale. In this project, a new graft
copolymer of poly(allylamine) -g- poly(ethylene glycol) was synthesized and processed to
create cellular array templates. In parallel with it, poly(ethylene glycol) hydrogel were applied to
the fabrication of cellular arrays. Cellular arrays generated on the interfaces of these two
materials were tested as living cell-based immunological sensors.
This thesis is composed of six chapters. Briefly, the objective of this project and some
background information are described in Chapter 1. Chapter 2 focuses on the synthesis and the
properties of poly(allylamine) -g- poly(ethylene glycol). Chapter 3 describes cellular array
fabrication on the graft copolymer based templates. In Chapter 4, a new system based on
poly(ethylene glycol) hydrogel is introduced. Chapter 5 focuses on the immunological sensor
application of cellular arrays produced on hydrogel system. Finally summaries follow in Chapter
6. Some extra information is available in appendices.
1.2 Background
1.2.1 Polyelectrolyte multilayers
Polyelectrolyte multilayers have been utilized as common substrates for various purposes in
this project. Even though only the surface properties have been exploited in this research,
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polyelectrolyte multilayers have great potential in many applications and various aspects are
introduced here.
1.2.1.1 Polyelectrolyte multilayer as a tunable thin film
Polyelectrolyte multilayers have attracted much attention as easy-to-build but versatile thin
films. They are usually produced by dipping substrates alternately into polyanionic and
polycationic polymer solutions. Lately, sequential spin coatings of each polyelectrolyte solution
have also been applied to produce multilayers.24 Deposition of multilayers has been achieved on
numerous kinds of substrates such as glass, quartz, silicon, ceramics, and polymers. Another
merit of this process is that conformal coatings of thin films can be accomplished on substrates
of different shapes and sizes. The alternate deposition technique used for polyelectrolyte
multilayers can be applied to different systems where electrostatic interaction is absent. '2 5 26
Weak interaction such as hydrogen bonding and dispersion force can also yield multilayer thin
films with polymers such as poly(acrylamide), poly(ethylene glycol), and polyaniline.27 Many
kinds of functionally active materials, such as enzymes, DNAs, proteins, light emitting polymers,
conducting polymers, and nano-particles, have been incorporated in multilayers in numerous
applications. 28
Multilayer films are very stable in dry state. The mechanical integrity can be attributed in part
to interpenetration of polymer chains into neighboring layers. In many cases, interpenetration
and diffusion of polymer chains result in de-stratification and homogeneous blending of layered
structure. Internal architecture and surface composition of the films can be controlled through
simple variations of processing conditions, such as extra salt concentration and pH. Because,
unlike strong polyelectrolytes which are fully ionized in aqueous solution states, the degree of
ionization of weak polyelectrolytes are dependent on pH condition,29 structural properties of
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weak polyelectrolyte multilayers can be optimized by simply switching dipping solution pHs.
Less ionized polyelectrolyte chains (pH < pKa for polyanions / pH > pKa for polycations)
assume a more coiled conformation and therefore deposit a thicker layer. The solution pH
affects not only the ionization of adsorbing polyelectrolyte, but also the ionization of a counter
polyelectrolyte already adsorbed on the substrate. Electrostatic balance between these pair
polyelectrolytes determines the amount of new materials adsorbing on the substrate. Proper
choice of pH conditions thus allows simple means to control internal void volume and the
number of unpaired free charge groups within multilayers, which can be used of as templates for
firther processing.3 0 31
1.2.1.2 Multilayers in biological applications
A polyelectrolyte itself is a very useful material in many biological applications. Especially,
polyelectrolyte complexes have drawn attention as biomaterials because they resemble proteins
or carbohydrates in many aspects. Polyelectrolyte complexes possess hydrogel structure,
permeability to bodily fluids, low toxicity, hydrophilicity, good mechanical strength, and
inherent ability to bind with oppositely charged molecules, all of which are key features
attractive for biomedical use including drug delivery system, enteric coatings for drugs, dental
adhesives, blood compatible implant coatings, membranes for artificial kidney dialysis, contact
lenses, and scaffold materials for tissue regeneration. However, polyelectrolytes complexes,
which are typically formed by just mixing two solutions of oppositely charged polymers, are
difficult to process into desired forms, structures and compositions due to readily forming ionic
crosslinking.
Since this problem can be solved by the multilayer assembly technique, many biological
applications of polyelectrolyte multilayers have been suggested and areas of investigations are
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still growing. Several proteins and other biomolecules have been successfully integrated into
multilayers, including a pair of heparin and human serum albumin,3 2 myoglobin, ribonuclease A,
and lysozyme.3 3' Polyelectrolyte multilayers of alginate / poly-L-lysine have been assembled on
highly cell-adherent substrates to modify them non-adherent.34 Chitosan multilayers with
glycosaminoglycan or fluorinated polyelectrolytes have been studied for biological applications.
Besides multilayers of proteins or other biomolecules, a weak polyelectrolytes multilayer
system of poly(acrylic acid) (PAA) and poly(allylamine hydrochloride) (PAH) has been studied
as cell culture substrates. Variation of deposition pHs of the polymer pair has resulted in
dramatic changes in cell adhesion on the multilayer surface. No adhesion has been observed
with the multilayers built with pH 2.0 PAA and PAH solutions, while other pH conditions have
generated multilayer surfaces adhesive to fibroblast cells.26
1.2.2 Patterning
Fabrication of a living cell-based immunological sensor involves proper patterning strategies
that allow creation of 2-D or 3-D patterns with biocompatible materials. As cells and many
proteins are labile in organic solvents or toxic chemicals and in the dry state, it is highly
preferred that all fabrication processes are performed in aqueous environments. Simplicity and
economic aspect are also important factors in selecting proper patterning techniques. From these
points, softlithography is a useful patterning technique that can faithfully generate patterns in
micrometer scale. Two common methods in softlithography are introduced here.
1.2.2.1 Stamping
Microcontact printing has been used in a growing number of application areas to produce
chemical patterns on a substrate.3538 Especially in its earlier applications, self-assembled
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mnonolayers (SAMs) of alkanethiolates have been transferred on gold substrates by stamping and
formed a resist layer to etchants. Various functional groups have been introduced onto the
surface from a rich library of alkanethiol co-end functional groups.26 '3 9' 40 Microcontact printing
has been applied to a number of biological studies. In these researches, biomolecules such as
poly-L-lysine, bovine serum albumin, fibronectin, laminin and various antibodies had been
directly stamped on substrates or adsorbed on substrates patterned with protein adsorption
resistant materials and then several cell types were cultured on the patterned surfaces.41 '42
Stamped patterns have been utilized also as templates for further processing. Multilayers 3 7 and
colloid particles35 have been selectively deposited on the patterned surface.
A new technique, polymer-on-polymer stamping (POPS) has widened the area of stamping
application.43 Compared to the microcontact printing of self-assembled monolayers,44 for which
small oligomer molecules are transferred onto metal or inorganic surfaces via covalent bond
formation, polymeric materials are stamped onto the polymer surface in POPS through
electrostatic, van der Waals, or hydrogen bonding interactions as well as covalent bonding. A
diverse range of materials with numerous types of functionality and structure can be transferred
to form a stable patterned layer on a charged surface, including the surface of a polyelectrolyte
multilayer with tailored optical, electrical, or surface properties. Considering variety and
versatility of polymer materials, wide use of POPS can be envisioned in electrical, optical, and
biological areas.
1.2.2.2 Micromolding in capillaries (MIMIC)4 4
MIMIC is another simple patterning technique used in this project. Conformal contact
between a flat substrate and a PDMS stamp with relief structure forms a network of empty open
channels. After a prepolymer liquid spontaneously wicks into the channels by capillary force,
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the prepolymer filled in the channels cures into a solid structure. Once the PDMS stamp is
removed, a network of polymeric material remains on the substrate.
Due to its simplicity and patterning fidelity, MIMIC has been applied with a wide range of
materials,4 5 including UV or thermally curable prepolymers,4 6 carbon precursors,4748 structural
and functional polymers, 49 colloids,50'51 inorganinc salts,5 ' sol-gel materials,52 and biological
macromolecules. 53 However, the use of MIMIC is seriously limited to continuous structures or
patterns because prepolymer liquids cannot flow into isolated cavities.
1.2.3 Poly(ethylene glycol) (PEG) as biomaterial
A biomaterial interface bridging glass substrates and living cells should satisfy several
requirements. Not to mention it should be non-toxic to living cells, it should be able to mediate
cell-substrate interactions in the desired direction. Since living cells communicate with
extracellular environments through interactions with proteins, cell-substrate interactions can be
properly directed by tailoring protein interactions with substrates. In this aspect, PEG is a very
useful biomaterial that can create a protein adsorption resistant surface.5 4'55 In addition, a
specific protein can be selectively immobilized on PEG surface when PEG contains special
functional groups at chain ends. These features allow a good control over a myriad of proteins
commonly present in cell culture medium or in vivo.
Protein adsorption resistance of PEG originates in part from its high affinity to water
molecules. Protein adsorption on PEG surface necessarily accompanies desolvation of water
molecules. Because elimination of water molecules causes positive free energy change, protein
adsorption is not favored. Entropy reduction also contributes to positive free energy change
when de-solvated PEG is compressed by adsorbing proteins.56 '58
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The need for relatively stable materials that are resistant to the nonspecific adsorption of
proteins or other biomolecules is not only restricted to this project. In many other biological
applications, materials with such properties have been sought for. Among many other materials
reported to be resistant to nonspecific protein adsorption,59 '63 one of the most studied and most
exploited is PEG.63 -73 Various methods have been reported to create a stable coating of PEG on
substrates. In this project, two PEG based biomaterial interfaces have been investigated for a
living cell-based immunological sensor fabrication. They will be discussed in following chapters.
1.2.4 T cell activation 23
T cells play a critical role in cell-mediated immunity, which comprises the adaptive immune
system together with humoral immunity involving B cells. Whereas humoral immunity
neutralizes antigens or harmful molecules via antibodies secreted by B cells before they infect
host cells, T cells in cell-mediated immunity eliminate microbes that have already infected host
cells. T cells distinguish infected cells from normal cells by the presence of antigenic peptides
associated with major histocompatibility complex (MHC) molecules (p-MHC complexes) on the
surface of infected cells. When T cell receptors (TCRs) engage p-MHC complexes, activation of
the T cell initiates. The resulting responses are different for naive T cells and effector T cells.
Naive T cells are cells that have never encountered the antigens before. Once they meet the
antigen, they proliferate into a large clone and differentiate into effector and memory cells.
When effector cells meet the antigen again, they rapidly function to eliminate the infected cell.
A T cell does not respond to any antigen but rather is triggered only by specific target antigens.
The entire population of T cells is composed of many subpopulations, each of which contains
distinct TCR clones that recognize a specific antigen. T cells defend against invasion by
nn:icrobes by deploying the specific subpopulation that recognizes components of that microbe.
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The incredible diversity in TCR specificity required for this mechanism is achieved by
recombination of several gene segments. T cell progenitors in the bone marrow have genes in
their inherited, or germline, configuration, where gene loci responsible for TCR uo and chain
transcription consist of multiple variable region (V) genes (n = -50 for uo / 70 for 3 in human),
and constant region (C) genes (n = 1 for oc / 2 for 3 in human). Between V and C genes, several
small joining (J) and diversity (D) gene segments are located. (D genes are present only in 3
loci.) When progenitor cells commit to become T cells, recombination of gene loci occurs with
the help of enzymes called V(D)J recombinase. By recombination, one V gene is connected to
one D and one J segments, where the segments are selected randomly. Transcription of V-D-J
gene together with C gene transcription leads to a translation of TCR 3 chain and similarly, an ot
chain without a D segment. Different combinations of V, D, and J gene segments (combinatorial
diversity) produce a wide variety of TCR clones and even more diversity is induced by changes
in nucleotide sequences at the junctions of V, (D), J gene segments (junctional diversity),
providing the immune system with the ability to potentially produce - 1016 different TCRs.
At the molecular level, antigen recognition induces T cell responses through biochemical
pathways that involve the activation of enzymes, recruitment of adapter proteins, and production
of active transcription factors. When TCRs bind p-MHC complexes, multiple TCRs, including
CD3 and chains in TCR complex, and co-receptors, CD4 or CD8 are brought together.
Clustering of co-receptors activates Lck, a tyrosine protein kinase, attached to their cytoplasmic
tails. Activated Lck phosphorylates tyrosine residues in immunoreceptor tyrosine-based
activation motifs (ITAMs) of CD3 and (. Another tyrosine kinase called -associated protein of
70 kD, ZAP-70, binds to phosphorylated ITAMs of the ( chain and is also phosphorylated by
Lck, which activates ZAP-70. Enzymatically active ZAP-70 then phosphorylates various
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adapter proteins and enzymes recruited near the TCR complex. After this, two major signaling
pathways follow: the calcium-NFAT pathway and Ras-MAP kinase pathway. We will briefly
describe the calcium-NFAT pathway, since we exploit this pathway in our system.
The calcium-NFAT pathway is triggered by phosphorylation and thus activation of
phospholipase C (PLC) by ZAP-70. Active PLC catalyzes the hydrolysis of plasma membrane
inositol phospholipids, which generates inositol 1,4,5-triphosphate (IP3) as a byproduct. IP 3
binds to IP3 receptor (IP3R) on the membrane of the endoplasmic reticulum (ER), which
stimulates the release of Ca2 + ions stored in the ER. This initial release of intracellular Ca2 +
together with signals from the TCR complex triggers opening of the plasma membrane Ca2 +
release activated Ca2+ (CRAC) channels to allow the influx of extracellular Ca2+.74 Cytosolic
Ca2+ binds a protein called calmodium, which leads to activation of a phosphatase, calcineurin.
Activated calcineurin removes phosphates from nuclear factor of activated T cells (NFAT). The
reduced size of NFAT allows its migration into the nucleus, where it binds to and activates the
promoters of several genes.
1.3 References
(1) Wang, J.; Rivas, G.; Cai, X.; Palecek, E.; Nielsen, P.; Shiraishi, H.; Dontha, N.; Luo,
D.; Parrado, C.; Chicharro, M.; Farias, P. A. M.; Valera, F. S.; Grant, D. H.; Ozsoz,
M.; Flair, M. N. Analytica Chimica Acta 1997, 347, 1-8.
(2) Chaki, N. K.; Vijayamohanan, K. Biosensors & Bioelectronics 2002, 17, 1-12.
(3) Tu, Y. F.; Chen, H. Y. Biosensors & Bioelectronics 2002, 17, 19-24.
(4) Hong, M. Y.; Chang, J. Y.; Yoon, H. C.; Kim, H. S. Biosensors & Bioelectronics 2002,
17, 13-18..
21
(5) Naumann, R.; Baumgart, T.; Graber, P.; Jonczyk, A.; Offenhausser, A.; Knoll, W.
Biosensors & Bioelectronics 2002, 17, 25-34.
(6) Setford, S. J.; White, S. F.; Bolbot, J. A. Biosensors & Bioelectronics 2002, 17, 79-86.
(7) Perez-Luna, V. H.; Yang, S. P.; Rabinovich, E. M.; Buranda, T.; Sklar, L. A.;
Hampton, P. D.; Lopez, G. P. Biosensors & Bioelectronics 2002, 17, 71-78.
(8) Kurrat, R.; Walivaara, B.; Marti, A.; Textor, M.; Tengvall, P.; Ramsden, J. J.; Spencer,
N. D. Colloids and Surfaces B-Biointerfaces 1998, 11, 187-201.
(9) Rosa, C. C.; Cruz, H. J.; Vidal, M.; Oliva, A. G. Biosensors & Bioelectronics 2002, 17,
45-52.
(10) Dostalek, J.; Vaisocherova, H.; Homola, J. Sensors and Actuators B-Chemical 2005, 108,
758-764.
(11) Kawazurni, H.; Gobi, K. V.; Ogino, K.; Maeda, H.; Miura, N. Sensors and Actuators B-
Chemical 2005, 108, 791-796.
(12) Horacek, J.; Skladal, P. Analytica Chimica Acta 1997, 347, 43-50.
(13) Su, X. D.; Dai, C. C.; Zhang, J.; O'Shea, S. J. Biosensors & Bioelectronics 2002, 17,
111-117.
(1]4) Cooper, M. A.; Dultsev, F. N.; Minson, T.; Ostanin, V. P.; Abell, C.; Klenerman, D.
Nature Biotechnology 2001, 19, 833-837.
(15) Beyer, U.; Fleischer, A.; Kage, A.; Haueter, U.; Ehwald, R. Biosensors &
Bioelectronics 2003, 18, 1391-1397.
(16) Pizziconi, V. B.; Page, D. L. Biosensors & Bioelectronics 1997, 12, 287-299.
(17) Xu, G. X.; Ye, X. S.; Qin, L. F.; Xu, Y.; Li, Y.; Li, R.; Wang, P. Biosensors &
Bioelectronics 2005, 20, 1757-1763.
(18:) Pancrazio, J. J.; Whelan, J. P.; Borkholder, D. A.; Ma, W.; Stenger, D. A. Annals of
Biomedical Engineering 1999, 27, 697-711.
(19) Gray, S. A.; Kusel, J. K.; Shaffer, K. M.; Shubin, Y. S.; Stenger, D. A.; Pancrazio, J. J.
Biosensors & Bioelectronics 2001, 16, 535-542.
(20) Abdelghani, A.; Abdelghani-Jacquin, C.; Hillebrandt, H.; Sackmann, E. Materials
Science & Engineering C-Biomimetic and Supramolecular Systems 2002, 22, 67-72.
(21) May, K. M. L.; Wang, Y.; Bachas, L. G.; Anderson, K. W. Analytical Chemistry 2004,
76, 4156-4161.
22
(22) Rider, T. H.; Petrovick, M. S.; Nargi, F. E.; Harper, J. D.; Schwoebel, E. D.; Mathews,
R. H.; Blanchard, D. J.; Bortolin, L. T.; Young, A. M.; Chen, J. Z.; Hollis, M. A.
Science 2003, 301, 213-215.
(23) Abbas, A. K.; Lichtman, A. H. Basic Immunology. Functions and Disorders of the
Immune System, 1st ed. ed.; W.B. Saunders Company: Philadelphia, 2001.
(24) Cho, J.; Char, K.; Hong, J. D.; Lee, K. B. Advanced Materials 2001, 13, 1076-+.
(:25) Clark, S. L.; Hammond, P. T. Langmuir 2000, 16, 10206-10214.
(26) Yang, S. Y.; Mendelsohn, J. D.; Rubner, M. F. Biomacromolecules 2003, 4, 987-994.
(27) Stockton, W. B.; Rubner, M. F. Macromolecules 1997, 30, 2717-2725.
(28) Decher, G. Science 1997, 277, 1232-1237.
(29) Shiratori, S. S.; Rubner, M. F. Macromolecules 2000, 33, 4213-4219.
(30) Joly, S.; Kane, R.; Radzilowski, L.; Wang, T. C.; Wu, A.; Cohen, R. E.; Thomas, E.
L.; Rubner, M. F. Langmuir 2000, 16, 1354-1359.
(31) Wang, T. C.; Chen, B.; Rubner, M. F.; Cohen, R. E. Langmuir 2001, 17, 6610-6615.
(32) Houska, M.; Brynda, E. Journal of Colloid and Interface Science 1997, 188, 243-250.
(33) Ladam, Ci.; Schaaf, P.; Cuisinier, F. J. G.; Decher, G.; Voegel, J. C. Langmuir 2001, 17,
878-882.
(34) Elbert, D. L.; Herbert, C. B.; Hubbell, J. A. Langmuir 1999, 15, 5355-5362.
(35) Chen, K. M.; Jiang, X.; Kimerling, L. C.; Hammond, P. T. Langmuir 2000, 16, 7825-
7834.
(36) Clark, S. L,.; Montague, M.; Hammond, P. T. Supramolecular Science 1997, 4, 141-146.
(37) Clark, S. L.; Hammond, P. T. Advanced Materials 1998, 10, 1515-1519.
(38) Jiang, X.; Hammond, P. T. Langmuir 2000, 16, 8501-8509.
(139) Lahiri, J.; Ostuni, E.; Whitesides, G. M. Langmuir 1999, 15, 2055-2060.
(40) Zhang, S. G.; Yan, L.; Altman, M.; Lassle, M.; Nugent, H.; Frankel, F.;
Lauffenburger, D. A.; Whitesides, G. M.; Rich, A. Biomaterials 1999, 20, 1213-1220.
(4 1) Branch, D. W.; Wheeler, B. C.; Brewer, G. J.; Leckband, D. E. IEEE Transactions on
Biomedical Engineering 2000, 47, 290-300.
(42) Craighead, H. G.; James, C. D.; Turner, A. M. P. Current Opinion in Solid State and
Materials Science 2001, 5, 177-184.
(43) Jiang, X. P.; Zheng, H. P.; Gourdin, S.; Hammond, P. T. Langmuir 2002, 18, 2607-2615.
23
(44) Xia, Y. N.; Whitesides, G. M. Annu. Rev. Mater. Sci. 1998, 28, 153-184.
(45) Kim, E.:, Xia, Y. N.; Whitesides, G. M. Nature 1995, 376, 581-584.
(46) Xia, Y. N.; Kim, E.; Whitesides, G. M. Chemistry ofMaterials 1996, 8, 1558-1567.
(47) Schueller, O. J. A.; Brittain, S. T.; Marzolin, C.; Whitesides, G. M. Chemistry of
Materials 1997, 9, 1399-1406.
(48) Schueller, O. J. A.; Brittain, S. T.; Whitesides, G. M. Advanced Materials 1997, 9, 477-
&.
(49) Zhao, X. M.; Stoddart, A.; Smith, S. P.; Kim, E.; Xia, Y.; Prentiss, M.; Whitesides, G.
M. Advanced Materials 1996, 8, 420-&.
(50) Kim, E.; Xia, Y. N.; Whitesides, G. M. Advanced Materials 1996, 8, 245-&.
(51) Kim, E.; Xia, Y. N.; Whitesides, G. M. Journal of the American Chemical Society 1996,
118, 5722-5731.
(52) Trau, M.; Yao, N.; Kim, E.; Xia, Y.; Whitesides, G. M.; Aksay, I. A. Nature 1997, 390,
674-676.
(53) Delamarche, E.; Bernard, A.; Schmid, H.; Michel, B.; Biebuyck, H. Science 1997, 276,
779-781.
(54) Walton, I). G.; Soo, P. P.; Mayes, A. M.; Sofia-Allgor, S. J.; Fujii, J. T.; Griffith, L.
G.; Ankner, J. F.; Kaiser, H.; Jhansson, J.; Smith, G. D.; Barker, J. G.; Satija, S. K.
Macromolecules 1997, 30, 6947-6956.
(55) Irvine, D.. J.; Mayes, A. M.; Satija, S. K.; Barker, J. G.; Sofia-Allgor, S. J.; Griffith, L.
G. Journal of Biomedical Materials Research 1998, 40, 498-509.
(5;6) Jeon, S. I.; Lee, J. H.; Andrade, J. D.; Gennes, P. G. D. Journal of Colloid and Interface
Science 1991, 142, 149-158.
(57) Jeon, S. I.; Andrade, J. D. Journal of Colloid and Interface Science 1991, 142, 159-166.
(58) Wang, R. L. C.; Kreuzer, H. J.; Grunze, M. Journal of Physical Chemistry B 1997, 101,
9767-9773.
(59) Holland, N. B.; Qiu, Y. X.; Ruegsegger, M.; Marchant, R. E. Nature 1998, 392, 799-801.
(60) Luk, Y. Y.; Kato, M.; Mrksich, M. Langmuir 2000, 16, 9604-9608.
(61) Amanda, A.; Mallapragada, S. K. Biotechnol. Prog. 2001, 17, 917-923.
(62) Ostuni, E.; Chapman, R. G.; Holmlin, R. E.; Takayama, S.; Whitesides, G. M.
Langmuir 2001, 1 7, 5605-5620.
24
(63) Zhang, Z.; Menges, B.; Timmons, R. B.; Knoll, W.; Forch, R. Langmuir 2003, 19,
4765-4770.
(64) Gombotz, W. R.; Guanghui, W.; Hoffman, A. S. Journal of Applied Polymer Science
1989, 37', 91-107.
(65) Gombotz, W. R.; Guanghui, W.; Horbett, T. A.; Hoffman, A. S. Journal of Biomedical
Materials Research 1991, 25, 1547-1562.
(66) Houseman, B. T.; Gawalt, E. S.; Mrksich, M. Langmuir 2003, 19, 1522-1531.
(67) Maechlingstrasser, C.; Dejardin, P.; Galin, J. C.; Schmitt, A.; Housseferrari, V.;
Sebille, 3.; Mulvihill, J. N.; Cazenave, J. P. Journal of Biomedical Materials Research
1989, 23, 1395-1410.
(68) Lee, J. H.; Kopeckova, P.; Kopecek, J.; Andrade, J. D. Biomaterials 1990, 11, 455-464.
(659) Sheu, M. S.; Hoffman, A. S.; Ratner, B. D.; Feijen, J.; Harris, J. M. Journal of
Adhesion Science and Technology 1993, 7, 1065-1076.
('70) Park, S.; Bearinger, J. P.; Lautenschlager, E. P.; Castner, D. G.; Healy, K. E. Journal of
Biomedical Materials Research 2000, 53, 568-576.
(71) Ruiz-Taylor, L. A.; Martin, T. L.; Zaugg, F. G.; Witte, K.; Indermuhle, P.; Nock, S.;
Wagner, P. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 852-857.
(72) Huang, N. P.; Michel, R.; Voros, J.; Textor, M.; Hofer, R.; Rossi, A.; Elbert, D. L.;
Hubbell, J. A.; Spencer, N. D. Langmuir 2001, 17, 489-498.
(73) VandeVondele, S.; Voros, J.; Hubbell, J. A. Biotechnol. Bioeng. 2003, 82, 784-790.
(74) Winslow., M. M.; Neilson, J. R.; Crabtree, G. R. Current Opinion in Immunology 2003,
15, 299-307.
25
2 Patternable PEG Grafted Poly(allylamine): Synthesis,
Characterization and Bio-surface Applications
2.1 Introduction
As various patterning techniques have emerged, the idea of patterning biological systems such
as nucleic acids, ' 2 proteins, 3 10 or cells3' 5-25 has become more and more prevalent for numerous
applications such as biochips or biosensors. Surface patterning for biological applications ranges
fiom topographical patterning 12' 14 17'1821' 26 to chemical patterning, 9'192 72 8 and the applied
techniques vary depending on the goals of the studies. Microcontact printing has been widely
used to create patterns of alternating chemical surface functionality; 3' 4' 103 19,2425,29-3 1 self-
assembled monolayers (SAMs) of various functionalities have been used to produce surfaces
with patterned biofunctionality, either through selective adsorption of a protein, or direct
covalent immobilizations of biomolecules on the microcontact printed surface or direct stamping
of proteins. Such arrays have been used to template cellular arrays aimed at understanding
critical issues in cell biology such as motility, apoptosis, and proliferation. 3 ' 15'3 1
Compared to SAM based microcontact printing techniques that utilize thiol, siloxane or other
small molecules, the polymer-on-polymer stamping (POPS) method developed in our group has
advantages in the flexibility of both substrate and ink selection because molecular transfer can
occur in association with electrostatic, van der Waals, or hydrogen bonding interactions as well
as covalent bonding;3 2 33 furthermore, the multivalent nature of polymer systems allows the use
of weaker interactions while still maintaining a stable monolayer. For these reasons, POPS is a
universal approach, particularly when combined with the use of polyelectrolyte multilayer
platforms on various kinds of planar and nonplanar substrates. The ability to tailor the
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functionality and surface composition of polyelectrolyte multilayers opens a wider range of
potential polymer "inks". In addition, the molecular conformation of the stamped layer in the
POPS of weak polyelectrolytes can be tuned by adjusting the ink pH, providing a very simple
way to control the extent of functionalization in surface reactions. As reported in our previous
work,3 3 the thickness of a poly(allylamine hydrochloride) (PAH) layer transferred by POPS
varied with the pH of PAH ink due to corresponding changes in the molecular conformation of
the polyamine, and consequently, the number of RGD oligopeptides functionalized on the
surface layer varied with the number of free amine groups at the given molecular conformation.
On the other hand, the need for relatively stable materials that are resistant to the nonspecific
adsorption of proteins or other biomolecules has drawn attention from many researchers in bio-
related areas. Furthermore, it has become an important issue to render the surface bioactive via
immobilization of biomolecules without nonspecific adsorption of unwanted substances. Of the
many materials reported to be resistant to nonspecific protein adsorption,27 3034 36 one of the most
studied and most exploited is poly(ethylene glycol) (PEG).2436 -46 Various methods have been
reported to create a stable coating of PEG on substrates, including simple adsorption,3 8 39 surface
grafting by chemical cross-linking or irradiation,41'4 7 plasma polymerization, 3 63 740 and self-
assembled monolayer formation.'3 Copolymers of PEG and other polymers have also been
widely studied.38 39424850 While the PEG domain of the copolymer generates a bio-inert surface
with resistance to nonspecific protein adsorption, the remaining part of the copolymer enhances
binding with the surface and thus the stability on the coated surface. For the variety of purposes,
the functionalization of PEG homo or copolymers with biomolecules, such as oligopeptides,2 4'4 5
carbohydrates, 4 6 and proteins,4 4 has been performed to generate bio-specific surfaces.
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In this study, we discuss the synthesis and characterization of a new water soluble graft
copolymer, poly(allylamine) - g - poly(ethylene glycol) to satisfy multiple demands. The
polycationic backbone of poly(allylamine) has been studied extensively in our group in
association with polyelectrolyte multilayers and POPS. Here we demonstrate that the attachment
of PEG side chains to this weak polycation yields additional features of protein adsorption
resistance, in addition to all the advantages of weak polyelectrolytes, such as a tunable
monolayer thickness. The graft copolymer was used as an ink for POPS to generate micron-
scale, long-range patterns with high fidelity, and subsequent biotin or maleimide
functionalization was carried out through an amine-based surface reaction. Employment of the
surface reaction enabled the same surface to be functionalized with many different materials
without making all derivatives by tedious synthesis and purification steps.
This chapter describes the detailed synthesis, protein resistance and subsequent patterning of
this graft copolymer, and its use in the formation of antibody and other biomaterial functional
arrays using simple conjugation chemistries performed on polymer substrates. The development
of a simple means of patterning antibodies for specific dendritic or antigen presenting cell
systems could lead to a straightforward and useful means of creating arrays for immobilization of
a large number of cells relevant to the immune system. On a broader level, this capability opens
up the use of polymer stamping as a means of biofunctional patterning for a range of
applications.
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2.2 Experimental section
Materials
Poly(allylamine) (Mw 17,000, 20% in aqueous solution) from Sigma-Aldrich Co., St. Louis,
MO., tBoc-NH-poly(ethylene glycol)-N-hydroxysuccinimide (tBoc-NH-PEG-NHS) (Mw 3,400)
from Nektar Therapeutics, Huntsville, AL, Linear poly(ethyleneimine) (Mw 25,000) and
poly(acrylic acid) (Mw 90,000, 25% in aqueous solution) from Polysciences Inc., Warrington,
PA, sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane- 1 -carboxylate (sulfo-SMCC) and
sulfosuccinimidyl-6-(biotinamido) hexanoate (sulfo-NHS-LC-biotin) from Pierce Biotechnology
Inc., Rockford, IL, GRGDSPC peptide sequence with fluorescein from Biopolymers Laboratory
at MIT, CD44:FITC from BD Biosciences, San Diego, CA, and streptavidin from Molecular
Probes, Eugene, OR were purchased and used as received.
Synthesis
Poly(allylamine) 0.25 g (equivalent to 4.4 mM of allylamine repeat units) was dissolved in 0.1
M]I aqueous sodium bicarbonate buffer. 5.0 g (equivalent to 1.5 mM of polymer/0.1 M of EG
repeat unit) of tBoc-NH-PEG-NHS was added to the poly(allylamine) solution. Reaction
proceeded overnight under stirring at room temperature. Unreacted species were filtered out
using a stirred ultrafiltration apparatus (Millipore, Bedford, MA) with a 10,000 molecular weight
cut-off polyethersulfone filter. The graft copolymer was retrieved via vacuum distillation. The
synthesis of the graft copolymer is shown schematically in Figure 2.1.
Removal of the tBoc protecting group was done in neat trifluoroacetic acid (TFA). After 3
hours of stirring, the mixture was diluted with water, neutralized with NaOH, and filtered
through the molecular weight cut-off filter.
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GPC and NMR
All GPC measurements were run in a 0.8 M sodium nitrate aqueous buffer. The equipment was
calibrated with PEG standards obtained from Shearwater Co., Huntsville, AL.
NMR analysis of the graft copolymer was performed in D20 solvent with Bruker Spectrospin
400.
Zeta potential measurement
The graft copolymer was dissolved in deionized water to form a lwt % solution, without any
pH adjustment. ZetaPALS instrument (Brookhaven Instrument Co., Holtzville, NY) was used
to measure the zeta potentials of the graft copolymer solutions.
Surface plasmon resonance spectroscopy
Biacore 1000 SPR instrument (Biacore, NJ) was used for the study of protein adsorption on
graft copolymer coated surfaces. The setup of experiments is schematically illustrated in Figure
2.2a. The sensor chip substrate was made by the evaporation of titanium as an adhesion layer (1
nmn) followed by a gold layer of 40 nm on cover glass slips of 0.2 mm. Gold coated cover glass
was cut into a proper size for the sensor chip holder. A carboxylic acid terminated self-
assembled monolayer (SAM) was produced on the chip surface by immersing the gold coated
substrate into a 2 mM solution of mercaptohexadecanoic acid in ethanol for 3 hours. After
rinsing with ethanol and blow-drying with air, the chip substrate was mounted on the holder with
the use of epoxy glue. Carboxylic acid terminated SAM surface of the chip was coated with the
graft copolymer or poly(allylamine hydrochloride) (PAH) (Mw 90,000, Sigma-Aldrich Co., St.
Louis, MO) by clipping the chip into a 10 mM aqueous polymer solution for 15 minutes and
allowing adsorption to occur by electrostatic interactions. Polymer solution pH values were all
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adjusted to 11; for the graft copolymer with the tBoc protection groups, additional pH 7 solution
was prepared to investigate the effect of coating solution pH on protein adsorption resistance.
Bovine serum albumin (BSA) of 1 mg/mL concentration in PBS and RPMI cell culture media
were used in the protein adsorption experiments. Before the injection of protein solutions into
chip microfluidic channels, PBS buffer was applied for 2 minutes to equilibrate the coated
polymers to an aqueous environment. Protein solution was injected for 6 minutes, followed by
FIBS buffer injection for 12 minutes. Difference in resonance units (RU) at the ends of the first
injection of PBS buffer for equilibration and the second injection of PBS buffer following the
protein injection was taken as resonance unit change (ARU) due to protein adsorption. Flow rate
was set always at 5 pL/min except for the priming and purging steps.
Polyelectrolyte multilayer (PEM)
Polyelectrolyte multilayers assembled from the weak polyelectrolytes, linear
poly(ethyleneimine) (LPEI) and poly(acrylic acid) (PAA) were used in this study. A 10 mM
aqueous solution of each polyelectrolyte was prepared. The pH of the LPEI solution was
adjusted to 7.5, and pH of the PAA solution adjusted to 3.5. A glass cover slip was cleaned by
ultrasonication in detergent solution for 3 minutes, rinsed vigorously with deionized water, and
treated with ultrasonication in deionized water for 3 minutes. The cleaned cover glass slide was
immersed in the prepared LPEI solution for 15 minutes and then rinsed three times in deionized
water with gentle agitation for 2, 1, and 1 minute(s), respectively. After these 3 steps of rinsing,
the positively charged substrate that resulted from the adsorption of polycation, LPEI, was
submerged in the prepared polyanion, PAA, solution for 15minutes. Three rinsing steps
followed in the same manner. Alternating adsorptions of LPEI and PAA built up one bilayer of
polycation/polyanion, yielding a negatively charged surface for the next polycation layer
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adsorption step. This procedure was continued until 10 bilayers were deposited on the substrate
with the top-most layer being PAA.
Polymer-on-polymer stamping (POPS)
General procedure of POPS is schematically shown in Figure 2.2b. A 10 mM aqueous
solution of the graft copolymer at pH 11 was prepared as ink for POPS. A PDMS stamp was
immersed in ink solution for an hour to allow the ink polymer to adsorb on the PDMS surface.
Subsequently, the stamp was gently rinsed with deionized water and blow-dried with air. The
dried stamp was then placed on the negatively charged multilayer substrate. After 2 minutes of
contact with the inked stamp, the substrate was vigorously rinsed with deionized water to remove
excess material loosely bound on the substrate. The stability of the stamped layer was tested by
ultrasonication for 2 minutes in deionized water.
Antibody adsorption
The substrate, patterned with the graft copolymer by polymer-on-polymer stamping was
immersed in 1 pg/mL solution of fluorescence labeled antibody of CD44:FITC for 10 minutes
and then rinsed in PBS buffer for 2 minutes under ultrasonication. After blow-drying the
substrate with air, antibody adsorption on the patterned surface was examined via fluorescence
microscopy.
Surface biotinylation and streptavidin coupling
A 1 mM solution of sulfo-NHS-LC-biotin was prepared in PBS buffer. The POPS-patterned
substrate was submerged in the prepared sulfo-NHS-LC-biotin solution. After an hour of
reaction between sulfo-NHS-LC-biotin and amine groups of the patterned graft copolymer, the
32
substrate was washed with deionized water and blow-dried with air. The substrate was immersed
in the 10 mM graft copolymer aqueous solution for 15 minutes to backfill the unstamped area.
The substrate was rinsed with deionized water and blow-dried with air.
A streptavidin solution (1 /tg/mL) was prepared in PBS buffer. The substrate, after
biotinylation and backfilling with the graft copolymer, was dipped in the streptavidin solution for
10 minutes, rinsed with PBS buffer, and stored in PBS buffer to minimize denaturation of
streptavidin until further use.
RGDfunctionalization
A 1 mM solution of sulfo-SMCC was prepared in PBS buffer. The POPS-patterned substrate
was submerged in the prepared sulfo-SMCC solution. After an hour of reaction between sulfo-
SMCC and amine groups of the patterned graft copolymer, the substrate was washed with
deionized water and blow-dried with air. The substrate was immersed in the 10 mM graft
copolymer aqueous solution for 15 minutes to backfill the unstamped area. The substrate was
rinsed with deionized water and blow-dried with air.
A 0.5 mM solution of fluorescein-GRGDSPC peptide sequence was prepared in PBS buffer.
The substrate, after maleimide linker conjugation and backfilling with the graft copolymer, was
(lipped in the oligopeptide solution. The reaction proceeded overnight at room temperature and
was followed by rinsing for 2 minutes in deionized water under ultrasonication.
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2.3 Results and Discussion
2.3.1 Design, synthesis, and molecular characterization
A graft copolymer with an electrostatic polymer backbone and PEG side chains was
synthesized through the modification of commercially available poly(allylamine); the copolymer
was the product of the reaction between N-hydroxysuccinimide (NHS) ester functionalized PEG
chains and primary amine groups along the poly(allylamine) backbone, resulting in the formation
of amide bonds and loss of NHS leaving groups, as shown in Figure 2.1. The remaining
nonfunctionalized amine groups on the backbone serve as the basis for adhesion of the entire
graft copolymer to a negatively charged substrate. The degree of ionization of the graft
copolymer backbone adjusted through the pH of the aqueous polymer solution, can be used to
vary the thickness and density of functional graft groups of dip-coated or POPS transferred
layers of the graft copolymer.
The tBoc group at the PEG side chain end protects primary amine groups from auto-
condensation with the NHS ester at the other end. After the grafting step, tBoc protection can be
removed in neat trifluoroacetic acid to restore the primary amine groups at the ends of the side
chain for further use. The length of the PEG side chains can be varied; in this work, we selected
a molecular weight of 3400, which ensures strong protein resistance due to entropic and
hydration effects.51
GPC analysis (Figure 2.3) of the graft copolymer revealed a PEG-equivalent weight average
molecular weight of 148,000 and a polydispersity index (Mw/MN) of 2.8 for the tBoc protected
graft copolymer. Deprotection of the tBoc group was verified with NMR, based on the
disappearance of the tBoc hydrogen (-C(CH3 )3) peak at 1.32 ppm. No evidence of chain scission
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was detected in GPC or NMR data after cleavage of the tBoc protection groups in the highly
acidic solvent, trifluoroacetic acid.
Based on the molecular weight obtained from GPC data, the calculated average fraction of
functionalized repeat units along poly(allylamine) backbone, the grafting density, was about 13%,
and the composition ratio, weight of side chains to weight of backbone was about 7.7. These
calculations were based on the assumption that molecular weight of poly(allylamine) is 17,000 as
given by the manufacturer. The RI detector of GPC did not give any signal for poly(allylamine)
itself in 0.8 M sodium nitrate buffer possibly because the polymer adhered to the column packing
and did not elute.
Since the GPC column was calibrated using linear PEG standards, and because GPC data
analysis presumes a linear rather than a highly branched chain, it is in general less accurate for
these branched non-linear polymers. For this reason, we also attempted to determine the grafting
density of the copolymer using proton NMR spectra. However, due to the congestion and broad
shape of the peaks relevant to side group substitution, it was impossible to determine the grafting
density from the NMR data. Instead, we were able to obtain a second estimate of the grafting
density using zeta potential values. Two assumptions were required: (1) the zeta potential is
determined only by the number of charged amine groups on the molecule and (2)amine groups
on the backbone and at the end of the side chains contribute to the zeta potential to the same
extent.
The zeta potential of the tBoc protected graft copolymer molecule was + 4.24 ± 1.99 (mV) and
it increased to + 5.16 + 1.03 (mV) after the removal of tBoc protecting group. Based on the
assumption just mentioned, the 18% decrease in zeta potential of tBoc protected graft copolymer
compared to the deprotected graft copolymer corresponds to a graft density of 18%, which is in
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reasonable agreement with the value of 13% obtained from GPC measurements. Zeta potential is
known to be affected by many system parameters such as viscosity of media, size of molecule,
and the hydrodynamic interaction between media and molecule.52 Thus the calculation is subject
to uncertainty particularly in view of the first assumption. Thus, the grafting density calculated
from zeta potential is taken as an order of magnitude crosscheck of the GPC-based value.
2.3.2 Protein adsorption
To determine the extent of protein absorption on the graft copolymer surface, surface plasmon
resonance was used.5 3 Results of protein adsorption experiments are summarized in Figure 2.4.
Each resonance unit change (ARU) value was normalized by the ARU value of a PAH control
surface, and this relative value is plotted in Figure 2.4. RPMI cell culture media was employed
in addition to BSA to study the adsorption characteristics of other proteins since RPMI cell
culture media contains the whole bovine serum, not only albumin at 5 wt % concentration. It
was relevant to study protein adsorption in RPMI media because the graft copolymer would be
used with this media in the B cell array fabrication application. The magnitude of resonance unit
change (ARU) in the RPMI cell culture media adsorption was larger than in BSA adsorption due
to a higher concentration of proteins in RPMI media. ARU in BSA adsorption for the graft
copolymer coated surface ranged from 119 to 132 while in RPMI cell culture media it increased
from 202 to 280. 1 ARU is roughly equivalent to adsorption of 1 pg/mm 2 for most proteins. RU
signals reached steady state values within 6 minutes after initial contact with the protein solution,
and within 12 minutes in the case of PBS buffer. An exception was the carboxylic acid
terminated SAM surface, which experienced a slight linear increase to the end of the protein
adsorption period, but steady state value within 12 minutes of contact with PBS buffer. Due to
the large uptake of proteins, the PAH surface exhibited a slower increase in early stages of
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protein adsorption, but reached steady state values in about 3 minutes. The adsorption of protein
on the acid terminated SAM was lower than that on the PAH surface, primarily due to charge
interactions. The negatively charged BSA is more likely to adsorb on the amine rather than the
acid surface due respectively to electrostatic attraction and repulsion.
The graft copolymer coated sensor chips exhibited substantial resistance to protein adsorption
compared to a F'AH coated surface or a carboxylic acid terminated SAM surface, for both cases
of BSA and RPMI cell culture media. Although the concentration and composition of each
medium are quite different, the normalized (PAH control) response of each surface plotted in
Figure 2.4 reveals the same trends for two media. As in similar experiments reported in
literature,4 5 6 these results suggests that the competitive adsorption of RPMI media is dominated
by early adsorption of albumin, which is a small protein at higher bulk concentration.
Consequently, the SPR experiment successfully demonstrated the adsorption resistance of the
graft copolymer to BSA in single and competitive modes. The effectiveness of the templates in
the presence of other kinds of proteins was confirmed qualitatively when the graft copolymer
was stamped and dip-coated to create an adsorption resistant region to an antibody and
streptavidin, respectively, as illustrated in Figures 2.4, 2.5, and 2.6b.
In conclusion, the grafting of poly(ethylene glycol) onto poly(allylamine) did not compromise
the protein adsorption resistance of PEG, nor the electrostatic binding capability of
poly(allylamine). A stable protein adsorption resistant coating was created simply by dipping a
negatively charged surface (carboxylic acid terminated SAM) into the aqueous solution of the
graft copolymer. Adsorption of proteins on a poly(allylamine) coated surface was reduced to less
than 5 % of the original value by the introduction of PEG side chains. Deprotection of tBoc
groups had little influence on the adsorption resistance of the graft copolymer. The electrostatic
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interactions between proteins and amine end groups of PEG are evidently not large enough to
effectively counteract the inherent hydrated-state protein adsorption resistance of PEG;
furthermore, some of the amine groups generated by elimination of tBoc groups may bind to the
surface, yielding PEG side chain loops as a brush layer and thereby effectively decreasing the
number of amine groups available to interact with proteins.
Protein adsorption resistance of the graft copolymer coated surface was also investigated
through the attachment study of protein mediated binding cells. Inhibition of fibroblast (NR6
WT) attachment was verified on the graft copolymer surface as generally reported with PEG
coated surface in the literature (data not shown).
2.3.3 Patterning
The graft copolymer was stamped on the negatively charged surface of the 10 bilayers of
LPEI/PAA. The stamped patterns were studied with the use of fluorescence (FITC) tagged
antibody. The protein adsorption resistant pattern of the graft copolymer repelled antibodies, and
directed them to adsorb preferentially on the PAA exposed area of the multilayer, thereby
generating fluorescence contrast on the patterned surface. The result is presented in Figure 2.5.
in Figure 2.5, cross and square patterns were stamped with the graft copolymer. Subsequent
immersion of the patterned substrate into the FITC labeled antibody solution resulted in selective
adsorption of the antibody on unstamped background regions. There was no distinct difference in
pattern quality seen under the microscope between the graft copolymers with and without tBoc
protection groups. The POPS technique could create faithful patterns on the micron scale over
areas larger than -the order of cm2 .
Although PEG side chains dominate the composition of the graft copolymer by the above
mentioned factor of 7.7, the positively charged backbone of the graft copolymer facilitated
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successful transfer by POPS to the negatively charged multilayer surface. Although it is not
discussed in this paper in detail, we note that methoxy terminated PEG side chains of larger
molecular weight (Mw 5,000) have been grafted onto poly(allylamine) at much higher grafting
density, up to about 50%, using this approach. Even at this high composition of PEG
(composition ratio of 44.1), the graft copolymer was successfully patterned via POPS. PEG is
known to form hydrogen bonded complexes with poly(acrylic acid),57 which is the outermost
polymer layer of the thin film substrate. However, in a control experiment, poly(ethylene glycol)
of molecular weight 10,000 was directly stamped under the same conditions, and no evidence of
pattern transfer was found in optical microscopy and AFM scans following vigorous rinsing
procedures. These experiments suggest the important role of the polycationic backbone in
providing the capability to achieve strong binding of the polymer to negatively charged surfaces,
and clearly indicate the role of the amine groups of the polymer in binding to the top multilayer
surface.
As shown in the patterned image in Figure 2.5, the graft copolymer layer transferred on the
surface via POPS maintained its resistance to protein adsorption as in the case of the dip-coated
graft copolymer layer discussed in the previous section.
2.3.4 Surface derivatization
Biotin functionalized derivatives of the graft copolymer were made by surface reaction as
described in the experimental section. Since the amidation reaction of the NHS-activated
carboxylic acid is highly preferential towards primary rather than secondary amines,
biotinylation of the underlying LPEI was negligible. Biotinylation was possible for the graft
copolymer with tBoc protection groups, as well as the deprotected graft copolymer. Biotinylation
vvas indirectly confirmed by specific interactions of biotin with streptavidin. Fluorescence tagged
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streptavidin was used to detect the coupling of biotin with streptavidin, and patterns of the graft
copolymer were used in the biotinylation in order to achieve fluorescence contrast under the
microscope after streptavidin binding. A backfilling step followed biotinylation in order to
prevent nonspecific adsorption of streptavidin on un-biotinylated areas. These procedures are
schematically summarized in Figure 2.6, and the resulting streptavidin pattern is shown in
Figure 2.7a, where the cross and square patterns stamped with the graft copolymer were
biotinylated and subsequently conjugated with fluorescence labeled streptavidin. The graft
copolymer backfilled background regions maintain bio-inertness, while the biotinylated graft
copolymer patterns actively bind with streptavidin. RGD ligand immobilization on the patterned
surface was also performed by surface reaction as described in the experimental section. The
reaction between the maleimide linker (sulfo-SMCC) and the graft copolymer was based on the
:same NHS chemistry as the biotin linker (sulfo-NHS-LC-biotin), and the same selective
reactivity issue with LPEI applies in this case. The reaction between free sulfhydryl groups in
cysteine (GRGDSPC) and maleimide groups on the linker took place overnight in the dark to
prevent photobleaching of the fluorescein dye. Unreacted oligopeptides were removed by
ultrasonication in deionized water. The reaction was also indirectly confirmed by fluorescence
from fluorescein, and patterns of the graft copolymer were used in fluorescein labeled RGD
immobilization in order to achieve fluorescence contrast between the maleimide linker
conjugated region and the region backfilled after the maleimide conjugation. Similar results were
obtained with the graft copolymer with tBoc protection groups, as well as the deprotected graft
copolymer. The procedures used are the same as schematically shown in Figure 2.6, with the
exception that the maleimide functionality replaces biotin and the RGD oligopeptide ligand
replaces streptavidin in the scheme. The fluorescent image of the resulting ligand immobilization
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is presented in Figure 2.7b. 10 ptm circular dots of the graft copolymer in triangular and square
arrangements were derivatized with RGD oligopeptide as shown in fluorescence image.
In both cases. amine groups on the graft copolymer backbone, as well as those at the ends of
the PEG side chains, are available for amidation reactions that facilitate the biotinylation and
RGD immobilization schemes. In the case of tBoc protected graft copolymer, the only amine
groups available are those on the poly(allylamine) backbone; therefore, the successful
functionalization of these surfaces indicates that a large number of amine groups are available for
surface reaction from the graft copolymer backbone.
In the biotinylation case, although PEG side chains are much longer than the size of the biotin
molecules, streptavidin was successfully bound to the biotin on the graft copolymer despite the
presence of the PEG brush layer, which simultaneously prevented nonspecific streptavidin
adsorption in those regions where bound biotin was not present. Since poly(allylamine) is a weak
polyelectrolyte, at pH 11 some of the non-ionized fraction of amine groups might be exposed at
or near the top regions of the PEG brush layer as a consequence of the loopy chain conformation
of poly(allylamine) on the negatively charged substrate, thus making both polymer backbone
amine groups and sidechain graft amine endgroups accessible in the brush layer. The presence of
the polycation backbone in a loopy surface conformation does not seem to disrupt the hydration
layer produced by the PEG side chains, and thus prevents nonspecific interactions with large
protein molecules, while remaining accessible to small linker molecules such as biotin. Once
biotinylated, the great avidity of biotin and streptavidin binding allows streptavidin to bind to
biotin and sit atop the graft copolymer layer. Steric matters might not be an issue in RGD ligand
irmmobilization due to the small size of the RGD containing oligopeptide.
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The conformational variation of weak polyelectrolytes that is caused by the change of the
ionization fraction at different pH on adsorption (from the stamp ink or from solution) can be
exploited to control the extent of surface functionalization. In the case of poly(allylamine), for
example, fewer amine groups are protonated at high pH and more amine groups remain available
for surface reaction after adsorption. The capability of adjusting the number of available amine
groups provides an easy way to optimize the extent of functionalization using surface reactions.3 3
In a solution state reaction, however, a change of solution pH may cause a reactivity decrease of
the other reagent. For instance, NHS-activated carboxylic acid groups are more subject
hydrolysis at higher pH. In this case, the less reactive NHS chemistry obtained in solution would
counterbalance the larger amount of deprotonated amine groups on the poly(allylamine)
backbone at high pH; the extent of reaction would not be simply controlled by the adjustment of
pH. The same discussion can be extended to the graft copolymer with deprotected amine groups.
Some of the protonated amine groups used as PEG side chain end groups may also participate in
surface binding and loop formation as discussed in the protein adsorption section.
2.4 Conclusions
The dense grafting of PEG on poly(allylamine) backbone effectively combined the
characteristic functionality of each component and resulted in a patternable protein adsorption
resistant material. By combining the flexibility of various pre-patterning solution
functionalization conditions with post-patterning surface functionalization, the patternability and
the resistance to the protein adsorption of the graft copolymer enabled the fabrication of protein
arrays and B cell arrays over large areas in a controlled manner. Patterning surfaces with
specific functionalities can be useful in many applications such as fabrication of electronic or
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photonic devices, biochips, or biosensors. We are currently pursuing applications of the
poly(allylamine)-g-PEG graft copolymer in the area of biosensor fabrication, and results of those
studies will be reported in forthcoming papers.
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Figure 2.1. Schematic description of the synthesis of poly(allylamine)-g-poly(ethylene glycol)
graft copolymer.
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Figure 2.5. Polymer-on-polymer stamping (POPS) of the graft copolymer. The fluorescence
micrograph was obtained with the adsorption of FITC labeled antibody protein on
the graft copolymer patterned polyelectrolyte multilayer substrate; antibody adsorbed
on polyelectrolyte multilayer surface (bright background) while the graft copolymer
covered area blocked the adsorption of antibody (dark crosses and squares).
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Figure 2.6. Schematic procedures of surface biotinylation and sequential bindings of streptavidin
and biotinylated antibody.
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Figure 2.7. (a) Fluorescence micrograph of antibody array fabricated as depicted in Figure 2.6.
(b) Fluorescence micrograph of the graft copolymer pattern selectively surface-
derivatized with Fluorescein tagged RGD oligopeptide.
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3 Fabrication of large area two-dimensional B cell arrays
using poly(allylamine) - g - poly(ethylene glycol)
graft-copolymer patterned templates
3.1 Introduction
There is currently great interest in the design of imaging-based high-throughput cellular
analysis systems1' 2, platforms for rare event detection3 , ultrasensitive cell-based biosensors4 , and
lab-on-a-chip devices. These technologies, as well as fundamental studies of cell biology 5, could
be greatly facilitated by the use of screening surfaces that selectively immobilize cells with
arbitrary characteristics into defined arrays on a 2D surface. While techniques for patterning
adherent cells have been extensively investigated, such methods have not been accessible to non-
adherent cells such as non-adherent lymphocytes or certain types of stem/progenitor cells. Here
we present an approach to generate patterns of non-adherent B lymphocytes in single-cell arrays
over cm2 areas of polymer-coated substrates for pathogen detection and immunological
applications. The approach described is applicable to a broad range of culture surfaces, provides
high fidelity cellular patterns over entire culture surfaces with simple seeding and washing, and
can be readily extended and generalized to many cell types.
The idea of patterning cells onto surfaces has become more prevalent as various patterning
methods have emerged over the past several years6 . Most of these studies have focused on
fibroblast T" or endothelial cells11'13, with some exceptions such as nerve cells'4 1 5 and liver
cells8 '16. The patterning of these tissue-forming cells has been performed via techniques utilizing
adhesion receptor ligands such as fibronectin or RGD peptides, or non-specific adhesive
interactions with a number of organic surfaces7'9 1 '13 '15. On the other hand, important cell types
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such as certain types of stem cells 17' , non-adherent lymphocytes'9 , and certain tumor cells20 are
weakly adherent or non-adherent. The isolation of non-adherent cells in a 2D surface array has
not yet been reported, and presents new challenges. Arrays of lymphocytes could be particularly
useful for controlling the cell-cell contacts that dictate immune cell function while excluding
influences from interactions between the neighboring cells of the same type. Arrays of
lymphocytes also present new possibilities for ultrasensitive and rapid-detection biosensors4 .
HIere we present a reliable method to produce isolated B cell arrays utilizing nonlithographic
microscopic patterning over large areas and a novel functionalizable, protein adsorption-resistant
copolymer.
Because of their inherent weak cell-substrate adhesion, specific antibodies or streptavidin-
biotin were used for the immobilization of B cells into an array. A method of direct antibody
stamping21 can generate a patterned array, but it presents limitations in manipulating the binding
strength of antibodies on the surface, which is very critical in some cases. We thus chose to
prepare surfaces for which the attachment of cell-binding molecules to the surface via a spacer
group allows free orientation of the antibody. The cellular array requires a patterned array of
antibodies with optimized binding strength to a single cell, alternating with a non-adhesive,
cytophobic surface. We show here the key role of the cell-substrate binding interaction in
controlling the fidelity of large-scale single cell patterns.
3.2 Experimental Section
Materials
Pol-y(allylamine)-g-poly(ethylene glycol) was synthesized from poly(allylamine) (Mw 17,000)
and N-hydroxysuccinimide poly(ethylene glycol) with tBoc protected co-functional amine group
55
(Mw 3,400) as discussed in Chapter 2. After grafting, tBoc protection groups were cleaved by
treating with neat trifluoroacetic acid to restore primary amine groups at PEG side chain ends.
The deprotected graft copolymer was used in this study. Weight average molecular weight of the
graft copolymer was estimated to be 148,000 before the removal of tBoc protecting groups and
124,000 after the tBoc removal by GPC in sodium nitrate aqueous buffer. The fraction of grafted
repeat units of poly(allylamine backbone), grafting density, was estimated as 13 %. Deprotection
of tBoc groups were confirmed by NMR analysis. However, congestion of peaks and rarity of
chemical species of interest made it impossible to draw meaningful grafting density out of NMR
data. The order of magnitude of the grafting density, instead, was crosschecked with zeta
potential measurement, where a grafting density of 18 % was estimated.
Polymer-on-polymer stamping (POPS)
10 mM aqueous solution of the graft copolymer at pH 11 was prepared as ink. PDMS stamp
was gently put in ink solution for the ink polymer to adsorb on PDMS surface. After an hour,
stamp was gently rinsed with deionized water and blow-dried with air. After 2 minutes of
stamping, the substrate was vigorously rinsed with deionized water to remove excess materials
physiosorbed on the surface. Sonication for 2 minutes was sometimes used to test the stability of
the stamped layer. Weak polyelectrolyte multilayer of linear poly(ethylenimine) (LPEI) and
poly(acrylic acid) (PAA) was made from 10 mM aqueous solution of each polyelectrolyte and
used as a substrate for stamping. In order to reduce the ionic strength, NaCl was added to LPEI
solution to the concentration of 0.1 M. LPEI solution pH was adjusted to 7.5 and PAA solution
pHr to 3.5. For each layer, a cover glass slide was dipped in the polyelectrolyte solution for 15
minutes and rinsed in deionized water three times for 2, 1, and 1 minutes, respectively. 10
bilayers were built beginning with LPEI, terminating with PAA.
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Antibody adsorption
The substrate patterned with the graft copolymer via POPS was immersed in 1 Ptg/ml solution
of fluorescence labeled antibody of CD44:FITC (BD Biosciences) for 10 minutes and then
sonicated for 2 minutes in PBS solution for rinsing. After the substrate was blow-dried with air,
the pattern of adsorbed protein was seen under the fluorescent microscope.
Surface biotinylation and streptavidin coupling
1 mM sulfo-NHS-LC-biotin (Pierce Biotechnology, Inc.) solution in PBS was dropped on the
substrate just to cover the patterned area with the graft copolymer. The drop of biotinylating
solution was washed off after 1 hour with deionized water. Non-biotinylated region (PAA
surface of multilayer) was backfilled with the graft copolymer by immersing the substrate into
the graft copolyrner solution for 15 minutes. After rinsing with deionized water, substrate was
blow-dried before the addition of streptavidin. 1 Ptg/ml of streptavidin in PBS was applied in the
same way. After 10 minutes of coupling, the drop of streptavidin solution was rinsed off with
deionized water.
Antibody and B1 cell biotinylation
5 mg of sulfo-NHS-LC-biotin was added to 0.5mg of antibody dissolved in ml PBS. After 2
hours of reaction at 4 C, mixture was dialyzed to remove unreacted biotins. CH27 B cells were
cultured in RPMI 1640 containing 10 % FCS, 2 mM L-glut, 50 IM 2-mercaptoethanol, 100
U/mL penicillin, and 100 Plg/mL streptomycin22 . Biotinylated CH27 B cells were prepared by
addition of 0.5 mg of sulfo-NHS-LC-biotin into 25x106 B cell suspension in 1 ml PBS. After 30
minutes of reaction at room temperature, cells were rinsed with PBS 3 times and suspended in
RPMI media.
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B cell array fibrication
Drops of B cell suspension were put on the substrate containing a sufficient number of B cells
to cover the entire area of the pattern. 10 minutes after all cells precipitated down on the surface,
the substrate was turned over inside the RPMI culture media. It was held about 5 minutes until
cells fell off from the substrate. Sometimes it was gently shaken in the media to get rid of extra
cells on the pattern.
3.3 Results and Discussion
The patterned arrays of antibody were generated via the polymer-on-polymer stamping
(POPS)23 of a new graft copolymer, poly(allylamine)-g-poly(ethylene glycol) (Figure 3.1a).
Compared to the microcontact printing of self-assembled monolayers2 4 , for which small
oligomer molecules are transferred onto metal or inorganic surfaces via covalent bond formation,
polymeric materials are stamped onto the polymer surface in POPS through electrostatic, van
der Waals, or hydrogen bonding interactions as well as covalent bonding23. A diverse range of
materials with numerous types of functionality and structure can be transferred to form a stable
patterned layer on a charged surface, including the surface of a polyelectrolyte multilayer with
tailored optical, electrical, or surface properties. The great versatility of the graft copolymer used
here as the ink material in POPS comes from multiple features of the structure. The major
components of the graft copolymer are the poly(ethylene glycol) (PEG) comb branches, which
comprise 90% wt of the polymer. PEG is well known to possess protein adsorption resistance at
aqueous interfaces, and to act as a barrier to nonspecific cell attachment7 '9' 25. On the other hand,
the polycation backbone of the polymer, which is based on poly(allylamine hydrochloride)
(PAH), facilitates transfer of the polymer onto a negatively charged surface such as silicon oxide,
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or a negatively charged polyelectrolyte multilayer, to form a very stable and uniform polymer
layer. Similarly, the use of poly(lysine)-g-poly(ethylene glycol) graft copolymer has been
reported in the literature9'26 '2 7, including cell attachment control via micropatterning of the
surface. The PAH backbone used in this work was chosen based on its usefulness and our
experience with it in both patterning and multilayer assembly applications. Because only a small
portion of the amine groups of poly(allylamine) are protonated at the pH used for stamping, there
are many free amine groups left after it binds electrostatically to a negatively charged surface2 8 .
These free amine groups are available for surface reaction and their density can be adjusted
simply by changing pH of the PAH-g-PEG copolymer solution. Consequently, these features
enable the creation of a surface pattern derivatized with various functionalities with the
simultaneous suppression of non-specific interactions of other molecules with the surface. In this
study, PEG comb branches with tBoc-termini and amino-termini were used, but the variation in
'PEG termini did not significantly affect the properties of the PAH-g-PEG copolymer. All data
shown were obtained using the graft copolymer with amino-termini.
To provide a specific anchor for B cells, an anti-CD44 antibody was selected and immobilized
on the substrate. The simplest antibody array was prepared by the direct adsorption of the
antibody onto the patterned regions of a surface not coated by the graft copolymer. To
accomplish this system, PAH-g-PEG graft copolymer was stamped onto the negatively charged
surface of a polyelectrolyte multilayer (10 bilayers of linear poly(ethylenimine) (LPEI) /
poly(acrylic acid) (PAA)). The resulting surface consisted of alternating regions of PEG graft
copolymer and 10 ptm circles of negatively charged PAA. Antibody was allowed to adsorb onto
the pattern; due to the protein resistance of the graft copolymer, antibody adsorption could occur
only on the circular PAA exposed regions (Figure 3.lb). As described above, the amino-termini
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of the PEG side chains do not support protein binding to regions coated by the graft copolymer.
Stability, uniformity, and bio-inertness of the graft copolymer pattern can be inferred from the
fluorescence image (Figure 3.1c) of the antibody array obtained as depicted in Figure 3.1b. B
cell array fabrication was completed with simple washing following the seeding of B cells onto
the antibody template. Although the general trend of the pattern can be recognized, it also
exhibits several imperfections, such as the aggregation of cells in interstitial spaces and empty
array spots containing no cells (Figure 3.1d). We hypothesized that these defects originated
from the weak binding of B cells to the antibody spot. Since the random adsorption of antibodies
on the PAA surface is likely to yield only a fraction of the antibodies in the desired functional
orientation, antibody arrays attained from simple adsorption are not likely to be effective enough
to immobilize B cells. Increasing the cell seeding density eliminated some empty cell sites, but
high seeding density had some drawbacks due to the increased occurrence of cell aggregate
formation. Once aggregation occurred, even bound cells were removed from the surface with the
aggregates, leaving empty spots and clumps of cells on the cellular array.
In order to address the issue of antibody orientation, we examined the use of a surface linker
group between the surface bound graft copolymer and the antibody (Figure 3.2a). A surface
template was produced by first stamping a PAH-g-PEG copolymer with amino-termini on the
PEG chains onto an LPEI/PAA multilayer platform. Via a simple surface reaction, biotin was
covalently linked to the amine groups on the 10pm of circular graft copolymer pattern. The
remaining PAA surface was backfilled with PAH-g-PEG unfunctionalized graft copolymer by
immersing the sample into a copolymer aqueous solution, leaving 10tm circular PEG-biotin
patches on the surface which were resistant to non-specific adsorption. Specific binding of
streptavidin to the biotin array on the otherwise bio-inert surface generated a streptavidin array
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template with a number of unoccupied binding sites remaining available. Finally, conjugation of
a biotinylated antibody to this streptavidin template led to the formation of an antibody array.
Compared to the first antibody array template, introduction of the biotin linker on the antibody
can give rise to greater orientational freedom of the antibody, resulting in more effective array
templates (Figure 3.2b). Cellular arrays on this template (Figure 3.2c) were greatly improved
over the first case. Even after intensive washing to remove clustered cells, many of the arrayed
cells remained. This type of array surface, utilizing a streptavidin-biotin interaction to bind
antibodies to the substrate, can be easily generalized to a large number of cell types simply by
altering the choice of biotinylated antibody used. This approach is of great interest because of its
flexibility; however, in this work, we performed following experiments to clearly demonstrate
the effects of increasing binding affinity on the ability to direct cells to the surface.
When using altibody-based immobilization, the binding avidity is determined by the number
of cell surface antigens and the antibody-antigen affinity. To further examine the importance of
binding strength on pattern fidelity, we labeled live B cells with biotin to introduce additional
high affinity cell-surface binding sites. In this case, the biotin molecules on the cell membrane
can participate in surface binding via conjugation with unoccupied streptavidin binding sites
(Figure 3.3a). Tihis enhanced binding led to a near perfect, clean array of B cells over large area
(Figure 3.3b) even at much lower cell seeding density. Biotinylated B cell arrays of comparable
quality were also achieved with the use of streptavidin array templates without antibody (Result
not shown).
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3.4 Conclusions
For the three approaches described above, two kinds of defects, (1) empty spots of array points
containing no cell and (2) undesired cells positioned in interstitial areas between array points,
were quantified (Table 3.1). These two parameters of pattern fidelity are not independent
variables; for a given array, the fraction of cells off the array sites cannot be controlled without
affecting the number of empty array sites, i.e. washing the surface to remove non-patterned cells
also tends to lower the number of cells bound on array spots. It is shown that both defect
parameters are reduced as the binding strength between the template and B cells increases.
Random biotinylation of membrane proteins may cause changes in receptor structures and thus
cell functions. However this issue may be addressed by incorporation of biotinylated lipid
molecules into cell membrane lipid layer29 , instead of direct biotinylation of the cell membrane.
In addition, our use of simple techniques for cell removal leaves room for further improvement
of the quality of cellular arrays.
The coincident development of microarray technologies and high-throughput optical image
analysis methods is rapidly leading toward the use of single cells as biosensors that will provide
new levels of detection sensitivity and the ability to rapidly quantitate the response of millions to
billions of cells to chemical libraries or complex analytes. To achieve the goals of such
technologies, we have described a technique that permits non-adherent B lymphocytes to be
patterned in arbitrary arrays over large surface areas within domains composed of single cells,
using simple seeding and washing steps. A general application of this approach to pattern other
non-adherent cell types should be readily achieved by cell-surface biotinylation or selection of a
suitable anchoring antibody. In addition to high-throughput technologies, new possibilities in
fundamental studies of multicellular interactions in the immune system and other areas of cell
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biology arise with the advent of substrates that allow precise immobilization of specific single
cells over entire culture surfaces.
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Figure 3.1. Fabrication of antibody and B cell array by simple adsorption of antibody. (a)
Chemical structure of poly(allylamine)-g-poly(ethylene glycol) copolymer. (b)
Schematic procedure of antibody array template fabrication. (c) Patterned array of
fluorescence labeled antibody. (d) B cell array fabricated with antibody array
template shown in (c).
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Figure 3.2. Fabrication of biotinylated antibody and B cell array. (a) Schematic procedure of
fabrication of patterned array of biotinylated antibody. (b) Array of fluorescence
labeled antibody fabricated by biotin-streptavidin conjugation. (c) B cell array
fabricated from patterned array of biotinylated antibody shown in (b).
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Figure 3.3. Fabrication of cellular array of biotinylated B cells. (a) Schematic presentation of
cellular array fabrication. (b) B cell array fabricated by random biotinylation of B
cell membrane proteins on patterned antibody array template shown in Figure 2c.
(The inset is a large area view of the array at lower magnification.)
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Table 3.1. Quantification of pattern fidelity.
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cell immobilization approach
streptavidin-linked streptavidin-linkedDefect type adsorbed antibody streptavidin-linked antibody +(Figure 3d) (Figure 3.2c) biotinylated cells
(Figure 3.3b)Empty array sites (%) 39.6 22.8 7.5
Cells off the array sites (%) 26.9 20.1 4.4
4 Cellular array fabrication using hydrogel microwell array
templates
4.1 Introduction
In the previous chapter, it was shown that antibody arrays can be effectively used as templates
for live cellular array fabrication. However, arrays built by binding of cells to flat substrates
presenting immobilized antibodies are susceptible to disruption by shear forces on the cells
caused by mishandling. For example, since the initial positioning of the cells is a stochastic
process, the probability for a cell to sediment on an antibody-patterned spot can be enhanced
through repetition of the positioning process. However, it is challenging to fabricate a perfect
cellular array through repeated cell seeding and washing because previously-positioned cells on
the array sites are disrupted by the mechanical agitation during the subsequent cell addition and
removal processes. We thus sought an alternative approach to further improve the quality of
single cell arrays produced by improving the mechanical stability of cell binding to the substrate.
To this end, the construction of a hydrogel microwell array was devised as a possible means to
diminish the effects of mechanical agitation; three-dimensional microwell structures with
dimensions comparable to the size of individual cells would be expected to protect the binding
interface between the cell and the antibody immobilized on the microwell floor from disruptive
mechanical force.
Beyond its extensive use in drug delivery and tissue engineering,1-8 hydrogels have been
employed in various cell patterning applications.9 -1 5 Cell patterning has usually been achieved
by culturing adherent cells on patterned hydrogel templates, where hydrogel patterns have been
fabricated via photolithographyl'"l or soft lithography.l21 3'15 Regions of the substrate not
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covered by the hydrogel template are rendered bioactive through non-specific protein adsorption,
so that cells grow only on protein-modified areas. After some hours of cell culture, extra cells
are removed when the cell culture medium is replenished. Another method of cell patterning has
been studied in association with tissue engineering scaffold fabrication, in which cells were
encapsulated in a hydrogel as it was polymerized into a solid matrix. 9' 14 In this approach, a cell-
containing hydrogel precursor solution is photopolymerized under a photomask to generate a
pattern of cells embedded in hydrogel. To create three dimensional structures, a
streolithographic apparatus is used. Three dimensional tissue engineering scaffolds fabricated by
this approach allow predetermined positioning of various types of cells required to constitute a
tissue in order to induce desirable cell-cell interactions.
For the present study, photolithography and soft lithography were combined to create hydrogel
microwell arrays using a photopolymerizable hydrogel precursor. With a simple chemical
modification of a polyelectrolyte multilayer-coated glass substrate, patterned hydrogels were
covalently linked to the substrate during gel polymerization. Biotinylated antibodies for cell
binding were subsequently immobilized onto the floor of the newly formed microwells.
Hydrogel microwell arrays modified with a desired antibody were then used as templates for
cellular array fabrication. Compared to the antibody array templates discussed in the previous
chapter, hydrogel microwell arrays alleviated difficulties in the cellular array fabrication process
and greatly improved the efficiency of the template.
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4.2 Experimental section
Materials
I-exyl phenyl ketone photoinitiator, poly(sodium 4-styrenesulfonate) (SPS, Mw 70,000) and
poly(allylamine hydrochloride) (PAH, Mw 70,000) from Sigma-Aldrich Co., St. Louis, MO,
poly(ethylene glycol) dimethacrylate (PEGDMA, Mw 1,000), Fluor 570 methacrylate, and
poly(acrylic acid) (PAA, Mw 90,000, 25% in aqueous solution) from Polysciences Inc.,
Warrington, PA, sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane- -carboxylate (sulfo-
SMCC) and sulfosuccinimidyl-6-(biotinamido) hexanoate (sulfo-NHS-LC-biotin) from Pierce
Biotechnology Inc., Rockford, IL, CD44:biotin from BD Biosciences, San Diego, CA, and
streptavidin from Molecular Probes, Eugene, OR were purchased and used as received. Peptide
rMCC (88-103; ANERADLIAYLKQATK) was produced by solid-phase synthesis and purified
by HPLC at the MIT Biopolymers Lab.
Polyelectrolyte multilayerdeposition
Cover glasses (24x50 mm, VWR, West Chester, PA) were used as substrates. Aqueous
solutions of PAA, PAH, and SPS were prepared to 10 mM concentration. PAH solutions were
prepared at two different pHs of 3.5 and 7.5. PAA and SPS solutions were prepared at pH 3.5.
Glass slides were cleaned through ultrasonication in detergent solution for 3 minutes, rinsed
rigorously with deionized water, followed by ultrasonication in deionized water for 3 minutes.
For polyelectrolyte multilayer buildup, the cleaned slides were immersed in polymer solution or
deionized water. The general dipping sequence is composed of 15 minutes in a polymer solution,
and three rinses in deionized water for 2, 1, and 1 minute(s), respectively. The buildup of
polyelectrolyte multilayer begins with polycationic polymer, followed by polyanionic polymer.
The sequence was repeated until the desired number of polyelectrolyte layers was deposited. For
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this study, three bilayers of PAH and SPS (both deposited at pH 3.5) were deposited followed by
three PAH (pH 7.5)/PAA bilayers with a final capping layer of PAH deposited at pH 7.5. The
three PAH/SPS bilayers improved the optical clarity and uniformity of the multilayer films.
Surface activation
Further functionalization was carried out on the polyelectrolyte multilayer coated substrates
through the primary amine groups of PAH. Maleimide functionality was introduced as a linker
to hydrogel structure and biotin functionality as a linker to streptavidin. A schematic diagram of
these surface functional groups is presented in Figure 4.1(a). Sulfo-NHS-LC-biotin and sulfo-
SMCC were dissolved to final concentrations of 1 mM for both in PBS buffer. The substrates
were submerged in the prepared reagent solution immediately after it was made. After an hour,
the substrates were rinsed rigorously with deionized water and blow-dried with air.
Hydrogel patterning by photolithography
A schematic diagram of photolithography is shown in Figure 4.1(b). As a precursor solution,
a 20 % PEGDMA (Mw 1000 g mol') solution in 25 % ethanol was used with 0.8 % hexyl
phenyl ketone photoinitiator. A lab bench UV lamp (8.9 mW/cm 2, 365 nm) was used as a light
source. A drop of 10 jiL precursor solution was placed on the photomask surface. A substrate
was gently placed over the drop and allowed to contact the precursor solution drop and compress
it under its own weight. After the precursor solution spread across the substrate spontaneously,
the photomask and the substrate, which were temporarily fixed to each other by surface tension
of the precursor solution, were carefully turned over and placed under the UV lamp. After 20
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seconds of UV irradiation, the substrate was peeled off the photomask, rinsed with DI water, and
blow-dried with air.
Hydrogel microwell array fabrication by soft lithography
In Figure 4.1(c), the procedures of the cellular array fabrication are schematically described.
Two conditions of hydrogel precursor concentration were used in this study; pure PEGDMA
mixed with a initiator solution was used to study swelling effects in contact with water and a
PEGDMA solution diluted to 20 % was mixed with a initiator solution to produce hydrogel
templates used in cell arraying applications.
Pure PEGDMA with a given molecular weight was mixed at a 1:1 volume ratio with a 0.2
g/mL hexyl phenyl ketone initiator solution in 70 % ethanol. Four different molecular weights of
PEGDMA were 200, 400, 600, and 1000. A diluted precursor solution was prepared as follows;
PEGDMA (Mw 1,000) was dissolved to a 20 % (v/v) concentration in 70 % ethanol, and hexyl
phenyl ketone to a 50 mg/mL concentration also in 70 % ethanol. A precursor solution was
prepared by mixing PEGDMA and the initiator solutions at a 1:1 volume ratio.
A PDMS stamp was placed on a substrate. Then a small volume of the precursor solution was
pipetted near the: edge of the stamp. By spontaneous perfusion, the precursor solution wicked
into channels between the stamp and the substrate. UV (1 mW/cm 2, 365 nm) was irradiated from
the bottom of the substrate for 2 minutes. After polymerization, the stamp was peeled off from
the substrate. For confocal imaging, 0.003 wt % Fluor 570 methacrylate was added to the
hydrogel precursor solution.
Antibody conjugation
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Anti-CD44 antibody was conjugated to the floor of the microwell via streptavidin-biotin
interaction. The PEG-based hydrogel microwell structure effectively resisted adsorption of
proteins and streptavidin and the antibody was immobilized only onto the PEM-coated glass
floor of the microwell. To accomplish the antibody conjugation, the hydrogel microwell array
was first soaked with a 1 tg/mL streptavidin solution for 15 minutes and then rinsed with PBS;
the substrate was then exposed to the biotinylated anti-CD44 antibody solution (0.5 tg/mL) for
15 minutes and finally rinsed with PBS.
Cells and cellular arrayfabrication
We stimulated 5C.C7 primary T cells taken from the lymph nodes of transgenic mice in the
presence of 1 tM MCC (88-103) peptide and maintained them in RPMI 1640 medium plus 10%
fetal calf serum (FCS), 2 mM L-glutamine, 50 pM [3-mercaptoethanol and
penicillin/streptomycin. T-cell blasts were used on days 3-7 for imaging experiments. Also a B-
cell lymphoma cell line, CH27, was used and maintained in the same medium.
Cellular arrays were made with use of a custom-made flow chamber setup. (Refer to the
appendix Al.) About 2x106 cells were added into the chamber (12x12x3.2 mm3). After 30
minutes, the flow chamber setup was turned upside down and a medium was purged into the
chamber until no drifting cells were seen.
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4.3 Results and Discussion
4.3.1 Hydrogel microwell fabrication by photolithography
The experimental setup for the photolithographic gel patterning is schematically depicted in
Figure 4.1(b). Although the thickness of the precursor solution layer between the photomask
and the substrate was -15 [tm (calculated from the volume of the drop and the surface area of the
substrate), the polymerized microwells were only 0.5 pIm deep as determined by AFM
measurements (Figure 4.2). This result suggests that polymerization occurred even in the
masked area designed to become microwells, leading to a continuous gel layer instead of a
microwell-containing gel. Since there is no accessible surface where the functionalized PEM-
coated glass substrate was exposed, these templates were not usable for antibody conjugation and,
thus, for cell arraying. The presence of a hydrogel layer covering the floor of the microwells was
verified by attempts to conjugate streptavidin to the wells, which would have bound to available
biotin groups if the functionalized substrate remained exposed. The pattern of the microwell
array could not be detected by fluorescence microscopy after incubation of the gels with FITC
labeled streptavidin (data not shown), unlike the case of the microwell array produced with soft
lithography discussed below and shown in Figure 4.5. Since the depth of depression changes
gradually as shown in Figure 4.2 (note that x and y axes of contour plot are not on the same
scale), it was not possible to detect the impressions with SEM, though it was observable by
optical microscopy.
The pattern on the photomask consisted of a square array of 10 lIm masked circles with 30 [tm
center-to-center separation along the edges of the square pattern. Photons with an incident angle
lower than 900 can undercut the masked area and polymerize the precursor polymer underneath.
Since the dimension of the unmasked area is comparable to the thickness of the precursor layer,
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stray photons from the un-collimated UV source have a large effect on the development profile
to undercut about 95 % of the 15 plm precursor solution layer. Adjustment of exposure time did
not result in any improvement. In conclusion, this study suggested that 0.5 jim is the
approximate threshold dry-state thickness that could be polymerized and developed faithfully
with a regular UV lamp.
4.3.2 Hydrogel polymerization using soft lithography
To overcome the limitation apparent in the photolithographic process described above, we next
tested a combination of soft lithography and photopolymerization. A hydrogel precursor
solution was perfused into open channels generated between a stamp and a substrate and cured
by UV irradiation. For the polymerization study, various molecular weights of PEGDMA (Mw
1200; 400; 600; 1,000) were tried. Although all tested molecular weights polymerized after the
perfusion process described in the experimental section, higher molecular weight polymers
exhibited more swelling in contact with water as expected. For PEGDMA monomers with a Mw
> 600 g/mole, stress buildup caused by swelling made the hydrogel structure delaminate from the
substrate; delamination initiated from the edge of the structure and propagated toward the center.
In contrast, PEGDMA of Mw 200 g/mole polymerized into a stable structure, and had no
delamination problems. Figure 4.3 presents confocal microscope images of some of these
hydrogel microwell arrays. For PEGDMA, Mw 1000, the image was taken near the center
region free of delamination effects. The influence of swelling is shown in the inward-leaning
tendency of the side walls of the microwell. This geometry of the side walls suggests that the
hydrogel structure is covalently linked to the substrate; without sulfo-SMCC surface linker,
hydrogel structures easily peeled away with the stamp when it was removed.
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To fabricate hydrogel microwells with the more protein-resistant (higher) molecular weight
PEGDMA which were also resistant to swelling-induced delamination, we added more solvent to
the precursor solution and polymerized gels in a 'preswollen' state similar to that of the final
equilibrium hydrogel. The hydrogel structure was stable in the dry state, as well. We found that
at this dilute monomer concentration, elimination of radical scavengers was necessary, because
the precursor solution perfused through channels of PDMS stamps failed to polymerize. This
problem was circumvented by polymerizing a precursor solution with 0.25 g/mL of the initiator,
five times the solution concentration used for the fabrication of microwell array templates from
low-Mw PEGDMA. It is noteworthy that once a stamp had been exposed to this higher initiator
content, it was then possible to use that stamp successfully with lower initiator concentrations.
This may indicate that initiators at a higher content quench a finite reservoir of radical
scavengers present in the stamp, including oxygen and other reagents dissolved in the PDMS,
thus enabling the subsequent polymerization of hydrogels even at a low content of initiator.
When a stamp is stored for a long time after use, these scavengers may regenerate but can be
eliminated by the same procedure.
Despite the necessity of extra steps, it is desirable to fabricate hydrogel microwell templates at
a lower initiator concentration to avoid toxicity to cells which could potentially be caused by
residual initiator trapped in the gel. One favorable aspect of this process is the fact that the
precursor solution exposed to air does not spontaneously polymerize at the lower initiator
content. Excess precursor solution left outside the stamp after perfusion remains uncrosslinked,
and can be rinsed off with water. Also, some oxygen molecules apparently permeate into the
PDMS channels and the polymerization does not proceed in regions close to the edges of the
stamp; when the, higher initiator content was employed, the precursor solution polymerized
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entirely and extra hydrogel structure formed around the edges of the stamp. This excess material
needed to be shaved off to obtain a microwell array of uniform thickness.
Some regions of the patterned hydrogel often appeared cloudy due to many tiny air bubbles
entrapped during perfusion of the gel precursor into the substrate-stamp gap. The shape of
cloudy area varied with the direction of perfusion, and cloudiness typically occurred in regions
that were downstream of the filling direction. Entrapment of air bubbles correlated with filling
speed of the precursor solution. When the solution was more viscous and moved slowly, a
higher rate of air bubble appearance was observed. Initially, the precursor solution wicked
rapidly into the channel; as the channels began to fill, the filling speed was reduced. For this
reason, the downstream region had a high occurrence of cloudiness. Also, this occurrence was
influenced by the presence of dust particles. If the filling stream intercepted a dust particle, it
changed the filling pattern and affected the cloudiness of the hydrogel structure. A preliminary
step involving polymerization of a higher initiator content precursor solution helped to remove
(Just particles and alleviated the problem of air bubble entrapment. In cellular array fabrication,
the cloudy area collected extra cells, which were impossible to remove.
Compared to the photolithographic approach, the soft lithographic technique described above
generated well-defined structures with a benchtop UV lamp. The backscattering SEM image
shown in Figure 4.4 clearly illustrates the well-defined 3D structures of the microwells. This
image was obtained with a non-gold-coated array of square microwells and the brighter floor
regions of microwells reflect the influence of electron-rich Si atoms in the glass substrate.
4.3.3 Antibody conjugation
PEG is one of the best known materials for the creation of protein adsorption resistant
substrates. As expected, the patterned PEGDMA hydrogels were effectively non-adherent to
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proteins. The soft lithographic approach produced a well-defined microwell structure, where the
substrate at the microwell floor remains unchanged during polymerization and retains exposed
biotin groups for streptavidin coupling. Differential interference contrast (DIC) and fluorescence
images of a streptavidin coupled hydrogel microwell array are shown in Figure 4.5. For
fluorescence microscopy, FITC-labeled streptavidin was conjugated to the microwell array; due
to the protein adsorption resistance of the PEG-based hydrogel, streptavidin was bound
predominantly to the microwell floor. After streptavidin was conjugated, biotinylated anti-CD44
antibody was coupled to streptavidin. Immobilization of the antibody was necessary to
immobilize cells inside microwells; otherwise, cells washed away along with the flowing
medium during rinsing steps.
4.3.4 Cellular array fabrication
The selected microwell size was based on the size of each cell type. For B cells, a hydrogel
microwell with a 14 tm diameter was used, and for T cells, 10 [tm. Although B cells are
generally bigger than 14 [tm, they could fit into smaller size microwells because the depth of the
microwell is only -6 [tm as determined from confocal microscopy. Figure 4.6 presents confocal
microscope images of cellular arrays. Cells were stained with FITC labeled anti-CD44 antibody.
Although B and T cells were immobilized to the microwell floor with anti-CD44 antibody, there
were CD44 molecules on cell membrane that did not participate in cell immobilization, and they
were stained with FITC labeled anti-CD44 antibodies. The confocal microscope images show
that both B and T cells were taller than the microwell.
Results with different sizes of microwell arrays are presented in Figure 4.7. The use of a 14
tlm microwell array was advantageous in locating cells at the center of each microwell and thus
aligning them into an array. On the other hand, a larger microwell has benefit in producing a
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cellular array because more space is available in the microwells, which provides the larger
probability of the cell positioning inside the microwell. However, repeated additions of cells on
the same template can compensate for the smaller probability of cell positioning in a microwell
and, as shown in Figure 4.7, the pattern fidelity of the cellular array is the same for both the 14
pm and 20 gm microwell.
Although the depth of the microwell was only about 6 [tm, it prevented disruption of cell
patterns by air bubbles. Without microwells, air bubbles trapped inside the flow chamber would
destroy a cell pattern as they swept across it during medium purging. Since cell binding was
stable in the hydrogel microwells, air bubbles were intentionally introduced into the flow
chamber and utilized to eliminate extra cells sitting outside the microwells. Extra cells usually
adhered loosely to one another and formed clumps. They were observed to wobble at high
purging rate, but sometimes, flow was not effective enough to remove these cells, and air
bubbles were required to accomplish it. However, as mentioned above, extra cells clumping on
the cloudy area of hydrogel layer were often bound too strongly to be removed with air bubbles.
In addition to protection from shear forces during cell arraying, the microwell plays another
role in cellular array fabrication. As cells were added onto a microwell array template, they slid
across the hydrogel surface until they lost momentum. While sliding, if they came across a
microwell, they fell into it, which increased the probability of cell positioning inside microwells.
This positioning by sliding into a microwell was observed even for hydrogel patterns produced
by photolithography (Figure 4.8), where the depth of the wells was only 0.5 jpm in the dry state.
This small depression on the surface was deep enough for cells to be trapped at low cell seeding
density. However, since cells were simply resting on the dimples and not bound to the
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photolithographically produced gels by receptor-ligand interactions, the cell pattern was
disrupted even by gentle disturbance and there was no way of eliminating extra cells selectively.
4.4 Summary
Microwell arrays with desired structure parameters could be generated by simple perfusion and
photopolymerization of PEGDMA hydrogel precursors. A soft lithographic technique used in
the study had great advantages in cost and simplicity of the process. Producing a well-defined
microwell structure of hydrogel was essential in utilizing extra functionality, biotin in this study,
on the floor of rnicrowells.
A microwell array facilitated the sequestering of cells and protected the sequestered cells from
external mechanical stimuli, which made it easy to repeat the process of cell addition and extra
cell removal. Perfect cellular arrays could be made by repetition of cell seeding and rinsing and
pattern fidelities of cellular arrays were reproducible when hydrogel microwell array templates
were used.
With good reproducibility of the high pattern fidelity, cellular arrays are ready to be employed
in further applications in biosensors, or fundamental biological studies with a high throughput.
In the next chapter, the concept of living cell-based immunological sensor will be tested with use
of cellular array systems.
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Figure 4.2. AFMR image of hydrogel pattern produced via photolithography.
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Figure 4.3. Confocal images of hydrogel microwell arrays made of PEGDMA (a) Mw 200
g/mole, and (b) Mw 1,000 g/mole.
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Figure 4.4. SEM backscattering image of a square microwell array taken in variable pressure
mode without gold-coating the sample.
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Figure 4.5. (a) Differential interference contrast (DIC) image and (b) fluorescence image of
hydrogel microwell array conjugated with FITC labeled streptavidin.
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Figure 4.6. Confocal microscope images of (a) T cell array and (b) B cell array.
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I
Figure 4.7. B cell arrays fabricated from (a, b) a 14 m hydrogel microwell array template and
(c,d) 20 [pm hydrogel microwell array template.
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I
Figure 4.8. (a) a T cell array and (b) a B cell array on hydrogel patterns generated by
photolithography.
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5 Fabrication of living cell-based immunological sensors
using cellular arrays
5.1 Introduction
The past decade or so has witnessed the introduction of new biological approaches based on
the idea of cell patterning. While various potential applications of cell patterning have been
discussed and suggested, '5 a majority of studies have concentrated on unraveling fundamental
aspects of cell biology.3 '6 ' 1 Although there have been some efforts to bridge microelectronics
and cell biology, 2' 13 few have been successful in creating bio-devices based on cell patterning.
Thus, we investigated the utility of cellular arrays for the creation of living cell-based
immunological sensors. T cell arrays fabricated as discussed in the previous chapter were placed
under multiple B cell layers and stimulated with known amounts of target peptides, or antigens to
determine if the system could yield quantitative responses to given doses.
The motivation for a biosensor utilizing living T or B cells derives from a number of
considerations: first, T cells are activated by recognition of specific peptide sequences. In vivo, a
tremendous diversity of antigen receptors is produced through recombination and expression of
receptor genes and each clone of cells has specific target antigens.14 Additionally, T cell
activation shows a dose-dependent response to antigens encountered by the cell. 5-'7
Consequently, specific antigens can be detected and quantified with an immunological sensor
built with the right clone of immune cells. Furthermore, it is possible to identify multiple
antigens if multiple clones of T cells are incorporated into separate arrays and exposed to an
unknown sample simultaneously or sequentially.
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The idea of a living cell-based pathogen sensor was put to the test by Rider et al.'8 In their
research, they genetically engineered B cells and added viruses into batches of the B cells. When
target viruses bound to specific antibodies on the B cell membranes, the resulting B cell
activation signal was detected using bioluminescent reporter proteins genetically encoded and
expressed in the! B cells. Extending the concept of using B cells as pathogen sensors, we have
employed T cells in 2 dimensional cellular arrays together with B cells as antigen presenting
cells (APCs). Since microbes are processed in APCs and T cells probe the fragments of
microbes bound to major histocompatibility complex (MHC) molecules on the APC
membrane,4'14 9 T cell-based sensors have the potential advantage of detecting non-mutatable core
peptide sequences from pathogens, making it more difficult to 'fool' the sensor by mutating the
structure of a target pathogen.
T cell activation14'20 is initiated by binding of the T cell receptor (TCR) to a specific MHC-
]peptide complex. This extracellular cue triggers an intracellular signaling cascade in the T cell
consisting of activation of enzymes, recruitment of adapter proteins, and production of active
transcription factors. Signal transduction to the nucleus results in cytokine transcription and cell
proliferation. Among other events, TCR triggering leads to a rapid increase in cytosolic Ca2+
levels. The initial release of intracellular Ca2+ stored in the endoplasmic reticulum in turn opens
Ca2+ release-activated Ca2+ (CRAC) channels on the plasma membrane and is followed by an
influx of exogenous Ca2 + through these molecular portals. 2 1' 2 2 This Ca2+ signal is known to
regulate gene expression patterns in T cells.23'24 Although it has been proposed that the temporal
pattern of Ca2+ signal oscillation, especially frequency, should play a role in determining T cell
responses,25,28 the mechanism is yet to be fully understood.
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The increase of cytosolic Ca2+ levels enables the measurement of the T cell activation strengths
via assessing fluorescence intensities of Ca2+ sensitive dyes, such as fura-2,2 9 loaded in T cells.
This approach has revealed correlations between Ca2+ level and the amount of antigen.
Importantly, the level and temporal pattern of intracellular Ca2+ elevation shows a dose
dependence on the amount of antigen encountered by the T cell,"' 1 7'30 even though individual
cells have typically shown large variations in their response to a given amount of
antigens. 5 192830 Thus, a large number of cells are necessary in a living cell-based
immunological sensor to obtain a representative response from broadly distributed individual cell
signals.
The proposed immunological sensor functions via quantification of the fura fluorescence
intensity change in T cells resulting from sequential activation events leading to a Ca2+ level
increase, which has been schematically illustrated in Figure 5.1 to compare to the B cell-based
sensor cited above. For our purpose, we have fabricated T cell arrays with T cells previously
loaded with fura-2; B cells were allowed to settle on the T cell arrays to establish cell-cell
contacts uniformrrly across the sample area. We have tested the system with various doses of
target peptides and examined its potential as a viable live-cell sensing device from several
aspects: sensitivity, response time, optimal measurement parameter, analysis automation, and
reliability. Furthermore, extension of its use as a high throughput individual cell assay platform
has been considered and discussed with an example of Ca2+ oscillation frequency analysis of
single cells. Based on single cell data collected at various doses, we have conducted tests to
determine if there is a correlation of Ca2+ oscillation frequency change with peptide dose.
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5.2 Experimental section
RP'MI medium preparation
RPMI 1640 medium was prepared with the addition of fetal calf serum (FCS) to a 10 % final
concentration, 50 ptM -mercaptoethanol, 2 mM L-Glut, 100 U/mL penicillin, and 100 [tg/mL
streptomycin. Phenol-deficient RPMI 1640 (imaging medium) was used for imaging
experiments to reduce the autofluorescence.
Cell culture
5C.C7 primary T cells3 ' taken from the lymph nodes of transgenic mice were stimulated in the
presence of 1 [tM moth cytochrome c (MCC) (88-103) peptide and maintained in RPMI 1640
medium. T-cell blasts were used on days 3-7 for imaging experiments. Since the absolute
signal levels recorded from blast cells varied from batch to batch, dose-response trends were
compared within the same batch of cells.
A B-cell lymphoma cell line, CH27, was used as an antigen presenting cell (APC) and
maintained in RPMI 1640 medium.
Calcium dye (fiura-2) loading into T cells
Fura-2 AM (Molecular Probes, Eugene, OR) was dissolved in dry DMSO at a 1 ltg/pL
concentration and stored at -20 C until later use; it was thawed at room temperature before
loading. T cells collected from a culture dish were ficolled to remove debris or dead cells. For
fura loading, -2x 106 T cells were re-suspended in 300 jiL of imaging medium and 6 uL of fura
stock solution was added to the T cell suspension. After 30-minute incubation at room
temperature, 700 tL of fresh imaging medium was added to the suspension, T cells were palleted
and re-suspended in 100 jpL of fresh imaging medium.
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T cell array fabrication
T cell arrays were produced using fura-2 loaded 5C.C7 T cell blasts following procedures
described in the previous chapter. Briefly, the prepared fura-loaded T cell suspension was added
into the flow chamber, which had a microwell-array-patterned substrate as a bottom plate. T
cells were allowed to settle on the substrate for 30 minutes during which the flow chamber was
placed at 4 C in order to slow cell metabolic events. The flow chamber was then closed and
turned upside down. Extra cells were re-suspended by carefully sweeping entrapped air bubbles
-across the substrate; cells correctly positioned in microwells remained bound to the antibody-
modified floors of the microwells. The re-suspended unpatterned T cells were allowed to settle
again on the patterned substrate for 30 minutes at 4 C; this repetition of cell suspension and
settling improved the pattern fidelity of cellular arrays. Typically 3 repetitions were used. The
imaging medium reservoir was kept on ice while extra cells were purged out. The purging
process continued until no drifting cells were observed.
B cell addition and MCCpeptide loading
After T cell array fabrication, the inlet and the outlet of the flow chamber were plugged to
prevent leakage and the cover plate was removed to allow access through the top of the flow
chamber. (Refer to the appendix Al for more information of the flow chamber structure.) Drops
of a CH27 B cell suspension (2.5x106 in 50 tIL imaging medium) were added into the flow
chamber through the hole. The flow chamber was next placed in an environmental chamber
installed on the microscope. The environmental chamber maintained the temperature at 37 °C
and the CO2 content at 5 %. Before the introduction of MCC peptide and the initiation of
microscopy, 10 minutes were allowed for the system to equilibrate and for B cells to settle onto
the T cell array. The number of B cells introduced in the flow chamber was large enough to
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form multiple continuous layers when they settled down on a T cell array. Focusing was also
achieved during this 1 0-minute waiting time.
MCC peptide stock solutions were prepared at various concentrations: 500, 100, 50, 10, 5, 1
pMs.. For dose-response experiments, 5 [tL of each stock solution was added into the flow
chamber, which has -500 pL total volume. Only for 10 tM dose experiments, 10 [IL of 500 itM
stock solution was added. MCC peptide stock solutions were carefully dropped into the flow
chamber not to disturb the B cell layers at the bottom. Immediately after the MCC peptide
introduction, time lapse microscopy was initiated. A schematic depiction of the system is shown
in Figure 5.2.
Time lapse microscopy and data analysis
In order to cover a large sampling area, 9 (3x3) adjacent fields of view were sequentially
scanned using a step-motor-controlled moving stage. For each field, fluorescence intensities
(emission of 510 nm) were measured at excitation wavelengths of 340 nm (exposure time: 400
ms) and 380 nm (exposure time: 100 ms), and then a differential interference contrast (DIC)
image was taken. One cycle (27 images over all 9 fields) took -30 seconds, after which the next
cycle immediately followed. Time lapse microscopy continued for 121 cycles for a total elapsed
time of 1 hour 7 minutes.
The fura ratio was defined as fluorescence emission intensity ratio at 340 nm excitation to
intensity at 380 nm excitation. Fura ratios of individual cells were calculated from fluorescence
images using MetaMorph® software (Universal Imaging Corp., Downingtowon, PA) and
tracked over one-hour time-lapse using Volocity( software (Improvision Inc., Lexington, MA).
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5.3 Results and Discussions
5.3.1 Ca2+ signal analysis
To quantify the activity levels of 5C.C7 blast T cells triggered by a given amount of the model
peptide analyte (MCC peptide) presented by CH27 B cells, we observed cytosolic calcium levels
in individual T cells over one hour after the addition of the peptides into the system. Calcium
levels in a cell were recorded by fluorescence microscopy using a calcium sensitive dye, fura-2.
The absorption spectrum of fura-2 shifts toward shorter wavelengths when it complexes with a
calcium ion. A cytosolic calcium level can be determined by comparing intensities of fura dye
loaded in a cell at two different excitation wavelengths, 340 nm and 380 nm, respectively. The
ratio of these two intensities is directly related to the intracellular calcium concentration, and has
been employed as a measure of the calcium level.
Individual T cells in a sample responded differently to a given amount of analyte peptide as
observed in the tracking of single cell Ca2 + levels. Examples of individual T cell Ca2 + responses
are presented in Figure 5.3. Ca2+ levels passed through maximum values, followed by a steady
plateau in some cells and a decrease in others. Maximum values and the rate of decay also
varied. Typically, the Ca2 + level in each cell exhibited oscillations but magnitudes and
frequencies of oscillations also varied from cell to cell. The average response for a set of 200 -
300 cells in the overall sample displayed a smoother curve, the shape of which was correlated
closely to the amount of added peptides.
Due to the wide variability of single cell responses, a large set of individual cell data was
desirable to obtain statistically meaningful average responses. The introduction of a cellular
array system facilitated collection of such large data sets and subsequent automated single cell
analysis. In regular B and T cell random co-cultures, T cells move around B cells until they find
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target peptides on B cell membranes. During this process, T cells often climb onto B cells or
clump together to form an aggregate of T cells, which occurs more frequently at a higher T:B
ratio. In these events, it is difficult to observe T cells via microscopy because T cells are out of
focus or fluorescence in aggregates of cells is indistinct. (Refer to the appendix A2.) On the
other hand, these problems were solved by the utilization of T cells arrays in which T cells were
evenly distributed and immobilized on microwell arrays. Isolated single cell arrays employed in
this study allowed the tracking of signals from 200 - 300 individual cells from a single array.
Although T cells were bound to microwells, their mobile character was retained and
lamellipodial extensions of large cells sometimes reached neighboring cells. On rare occasions,
T cells managed to escape out of microwells and crawled across the array. These situations
caused minor variations in the number of collected individual signals from sample to sample.
Some snapshots of T cell array responses (fura ratios) stimulated by MCC peptide antigens are
shown in Figure 5.4.
5.3.2 Average dose-response behavior
To illustrate its final application as a biosensor, quantitative characteristics of the system were
examined over a range of peptide analyte concentrations. As mentioned above, Ca2+ response
patterns of individual cells were distributed widely in time and magnitude space and only the
average response of all cells enabled direct comparison of responses among samples exposed to
different doses of peptide. As shown in Figure 5.5, the average fura ratios normalized to the
baseline level of' resting cells had a clear correlation with the dose of peptide. T cells from
different batche s prepared from different mice showed quantitatively, and sometimes
qualitatively, different average responses to the same dose of peptides. Figure 5.5 presents
representative dose-response behavior of one batch of T cells out of two similar dose responses
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obtained from two different batches. (See the appendix A3 for comparison between T cell
preparations.)
Increases in cytosolic Ca2+ were commonly witnessed for the range of doses tested in this
study. Within an experimental time frame (-1 hr), Ca2+ levels rose to saturation values for doses
greater than 0.5 [TM and increased monotonically for lower doses. A slight increase in fura ratio
was detected even for a control sample, to which no peptide was added; repeated UV exposures
affected the intensity of the fura dye more at 380 nm excitation than at 340 nm by
photobleaching and thus, caused their ratio to increase about 5 %. Although a 10 [M analyte
dose resulted in the most rapid increase of a Ca2+ level, the saturation level was almost the same
as at 5 pM. Determined from Figure 5.5, the responses were best resolved quantitatively in a
range of 0.05 p1\I - 5 KM, spanning two orders of magnitude in analyte concentration.
As the amount of added peptides increased, the slope of transient responses increased and the
time to saturation was shortened. In other studies, T cell responses showed a higher slope at
larger doses but the time taken for T cell responses to reach the peak value was independent of
dose.'15 16 This discrepancy may originate from the time delay involved in diffusion of the
peptide analyte in the medium to MHC molecules on B cell membranes; kinetic considerations
were made using the reported diffusion constant value for the peptide analyte and a simple
diffusion relation, < x2 > = 2Dt, where x is diffusion distance, D diffusivity, and t elapsed time.
lUsing 10' - 10" 7 (Cm2S-')3 2 for the diffusivity and 0.1 - 1 cm for the dimensions of the flow
chamber, the diffusion time scale falls in the range of 103 - 107 seconds; even the lower limit of
the range is comparable to the experimental time frame. Consequently, the transient responses
observed were influenced mostly by diffusion rate of peptide as well as binding kinetics of the
analyte to MHC molecules on the B cells in addition to T cell activation kinetics.
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In the past, Wilfing et al.30 have reported that 5C.C7 T cells have different oscillatory
characteristics of Ca2+ depending on the degree of transformation, i.e. from naive cells to once-
stimulated blasts and to multiply-stimulated blasts. However, the daily change of Ca2+ signal
magnitude within the same batch of cells has not been studied before. In an effort to test the
robustness of quantitative dose responses, we found that T cell blasts became more sensitive to
their target antigen at late times (5-7 days) after their initial stimulation in culture. Three
different peptide doses (0.05, 0.5, and 5 M) were added to immune sensors made with T cell
blasts at three different days of culture: day 3, 5, and 7, respectively. For a given peptide dose, T
cell responses were highest with day 7 cells and lowest with day 3 (Figure 5.6). At a given day,
experiments were carried out in the order of 5, 0.5, and 0.05 iMs. The earliest experiment (5
jM at day 3) exhibited a drastically different response relative to the later time points (5 jiM at
day 5 and 7) and the response gaps at different days became smaller after day 5.
Recognizing this culture age-dependence of responsiveness from T-cell blasts, subsequent
experiments were performed on day 5-7 except for 0 and 0.01 jiM, which were taken on day 3 or
day 4. (Refer to the appendix A3 for the comparison of all data.) Except for the culture age-
dependent responsiveness (Figure 5.6), results were presented and discussed based on batch 3
throughout this chapter. One noticeable difference between batch I and the other two batches
was the extent of proliferation. Although the cells were healthy and their morphology appeared
normal, batch 1 had undergone delayed proliferation compared to the other two batches; the
number of cells was less at the same time point of culture.
5.3.3 Living cell-based immune sensor
Based on the average dose-response curves, the concept of a living cell-based immune sensor
was scrutinized. Although the average responses showed resolved differences according to the
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amount of added peptide analyte, the method of tracking Ca2+ signals over an hour has some
drawback; fast response times and simple readout are highly preferred in a real sensor
application. Thus, we proposed an alternative involving only two readouts at time zero and 10
minutes after the introduction of analytes. The difference of these two readouts can serve well as
a signal strength parameter, as shown in Figure 5.7. The system worked best in 0.05 - 5 M
dose range, where the signal curve has a stiff slope.
It should be noted that the choice of 10 minutes was somewhat arbitrary. Since the kinetic
aspect of dose responses was mostly influenced by the diffusion process of peptide, modification
of the system dimensions or system setup will cause a change in the response kinetics, and the
optimum time point should be relocated accordingly.
5.3.4 Ca2+ signals from individual T cells
A large set of individual signals are useful not only for gaining average responses, but also for
studying single cell behaviors of interest. In this study, we also focused on single cell Ca 2+
responses. Figure 5.8 presents 3D plots of fura ratios from all individual cells that were used to
construct the average response curves in Figure 5.5. As discussed previously, individual cells
revealed a broad distribution of Ca2+ responses, although they collectively contributed to a
smoother average response; the surface defined by the fura ratio of each cell along the time axis
consisted of random spikes/valleys. Figure 5.8(a) presenting individual cell responses without
any added peptide reveals that the baseline Ca2+ levels also randomly fluctuate.
As an alternative to the average dose response discussed above, the correlation of Ca2+ signals
with dose could be confirmed by histograms of maximum fura ratios and sums of fura ratios over
the experimental time frame (Figure 5.9). As the system was exposed to a higher dose of
peptides, the population distribution shifted toward higher values for both maximum Ca2+ level
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and total Ca2+ responses. Comparison of the two histograms verifies that maximum increase in
cytosolic Ca2+ has a close correlation with the average increase as reported by Rotnes and
Bogen. 1 5
However, patterns of Ca2+ signals were far from the results of Wilfing et al.30 According to
their study, agonist MCC peptide had brought mostly "full" Ca2+ responses from 5C.C7 T cell
blasts, which was independent of the doses, whereas weak agonist peptides or antagonist
peptides had caused "reduced, partial, or transient" Ca2+ responses. In our results shown in
Figure 5.8, responses could not be categorized simply by any of the 4 Ca2+ response types used
in their study. Another disagreement lies in the rate of T cell activation at two different MCC
peptide doses: 25 and 0.025 i[Ms. Whereas they had observed that MCC peptides could activate
100 '0O of cells regardless of the dose condition, we found that even at 10 tM there were cells
with the same filra values as those of cells exposed to no peptide (0 jM) and this population
became larger at lower doses as shown in Figure 5.9. These discrepancies might be attributed to
the diffusion-limited kinetic characteristics of our system. Continuous diffusive influx of MCC
peptides onto MHC on B cells might maintain the overall Ca2+ response in a transient stage;
sporadic encounters of TCR-peptide-MHC can disturb Ca2+ patterns during the experimental
time frame. Concerning the activation rate, the actual amount of MCC peptide bound on MHC
might be much less in our case at the same dose. With the same actual amount of MCC-MHC
complexes, we might also find dose-independence of T cell activation rate. It is likely especially
because 5 and 10 [tM responses in our study show little difference in Figure 5.9.
We also tried to draw information of cytosolic Ca2+ fluctuation frequency from individual cells.
It has been reported that calcium signal mediates gene regulation. Especially, changes in gene
expression pattern have been detected with variations in Ca2 + oscillation frequencies.2 4 25 27 Thus,
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we investigated Ca2 + oscillation patterns by Fourier transformation of Ca2+ signal to test the
correlation between the oscillation frequency and the dose of peptides. The power spectrum is a
measurement of the power at various frequencies of a discrete Fourier series of Ca2+ signal.
Discrete Fourier transformation power spectra of Figure 5.8 data are presented as 3D plots in
Figure 5.10. Commonly, power spectra have strongest peak at a zero frequency (cycles per
minute), which represents non-oscillatory character (an extent of constant elevation of a Ca2+
level). Ignoring[ the highest peak at a zero frequency, the presence of a secondary or tertiary
peak was detected randomly among different cells exposed to the same dose, and also among
different sets of cells exposed to different doses; it was difficult to find the correlation within the
range of dose monitored in this study. However, there still exits a possibility that the oscillation
pattern had been affected by diffusion-limited delayed binding of MCC peptides to MHCs on B
cells. Better understanding of the correlation between dose and Ca2+ oscillation frequency awaits
more studies involving APCs previously loaded with peptides and probably, in a wider dose
range.
5.4 Conclusions and Perspectives
In this report, we have shown that cellular arrays of T cell blasts covered with uniform B cell
layers result in a functional living cell-based immunological sensor, or peptide detector. The
sensor produced in this research had an optimal working dose range of 0.05 - 5 tM. In this
setup, since B cells were already in contact with arrayed T cells before the addition of analytes, T
cells could get activated without delay in locating B cells. These arbitrary delays in random co-
culture experiments may raise challenges in realization of fast readout biosensors. Layered
arrangement of T and B cells cleared this unpredictability and enhanced the performance
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reliability, although there still remain other issues in reproducibility. Especially, variance of cell
activity among different batches of cells and among cells from the same batch at different days
of culture necessitates development of more robust T cell lines. In addition, lengthening the list
of available T cell lines with a larger repertoire of target proteins can bring forth a useful
diagnostic device that can read what kind of, in addition to how many, pathogens exist in a
sample.
The detection threshold, or sensitivity of a sensor can be shifted and optimized by reducing or
increasing the medium volume, and thus by changing diffusion rates. Even though the early
responses at 0.01 or 0.05 ptM were not clearly resolved from the zero responses (0 pM), the
responses diverged clearly at later stage of experiments. Thus, the lower detection limit will be
likely to move toward the lower dose direction with diminishing diffusion time scale, or vice
versa, if we fix the readout time, for example, 10 minutes as we proposed here.
We have also :studied the patterns of individual cell Ca2+ signaling with the aid of commercial
software. Unlike the magnitude of Ca2 + levels, oscillatory pattern of Ca2+ signal collected in this
research seemed to have no correlation with amount of peptides and rather appeared stochastic.
The study of individual cell Ca2+ responses exemplifies the potential application areas that
cellular array platforms can greatly contribute to. Recently, the importance of single cell study is
gaining attention as the conventional bulk assays often fail to provide information of a rare cell
subset of interest.2' 33' 34 A high throughput capability of an assay is essential for use due to the
small subset population of these cells. As microscope systems with scanning capability are
available, current technology may push microscopy to the high throughput limit."4 When
dealing with hundreds of millions of individual cells, an automation of acquired data analysis
process is a prerequisite for realization of a high throughput system. Cellular array platforms can
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facilitate the data analysis automation by use of commercial software, as discussed in results and
discussions section in this chapter.
Microscopy has some advantage over flow cytometry in that it can observe an evolution of
cellular events. However, this advantage would be compromised in a high throughput
microscopy based on scanning scheme. (In our research, it took - 30 seconds to cover only 9
sections.) Alternatively, we may accomplish a high throughput microscopy by incorporating a
microfabricated photonic array into a cellular array system as a signal detector. It can provide
easier tracking and analysis of single cell signals simply by aligning a photonic array detector to
a cellular array.
In addition, automated microinjection utilizing a cellular array platform may widen the
application area of a high throughput microscopy. Direct injection of cell staining probes into
individual cells will enable visualization of molecular events inside single cells without efforts of
developing cell permeable staining probes. When these systems become readily available, we
e nvision that cellular array platforms will find prevalent uses in various application areas.
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Figure 5.1. Schematic illustration of sensing mechanism of (a) the B cell-based sensor by Rider
et al. 18 and (b) the T cell-based sensor of the current study.
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Figure 5.4. Snapshots of T cell array activation by (a) 5 and (b) 0.05 VMs of MCC peptide
analytes. Pictures were taken at t = 10 minutes.
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6 Conclusions
6.1 Thesis summary
In this thesis, it has been demonstrated that a living cell-based immunological sensor can be
fabricated on the basis of the two PEG based biomaterial interfaces: poly(allylamine) -g-
poly(ethylene glycol) and poly(ethylene glycol) dimethacrylate. The both materials have been
rendered into patterned templates providing controls over substrate-protein interactions and thus,
substrate-cell interactions. Cellular arrays created on those templates have been investigated
aiming at living cell-based immunological sensor applications.
Chapter 2 discusses the synthesis, the characterization and the triple features of
poly(allylamine) -g- poly(ethylene glycol) graft copolymer: protein adsorption resistance,
patternability, and flexibility in further functionalization. While the polyelectrolyte backbone of
the graft copolymer facilitates the patterning via stamping by providing the stable binding of the
graft copolymer to the negatively charged surface, the PEG side chains provide high resistance to
protein adsorption. Desired functional groups can be introduced to the graft copolymer in a
solution state or in an adsorbed state via proper surface chemistry.
Chapter 3 demonstrates that the triple features allow successful use of the graft copolymer in
antibody array fabrication. Immobilized antibody configurations could be properly modified
with the use of the biotinylated graft copolymer. The results show that binding affinity between
cells and protein array templates plays a key role in achieving high pattern fidelity of cellular
arrays.
In Chapter 4, the work with poly(ethylene glycol) dimethacrylate hydrogel system is discussed.
The hydrogel can be simply patterned into a microwell array structure via micromolding using
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IPDMS stamp. It has been shown that topological structure of microwell arrays facilitates the
positioning of cells and enhances the mechanical stability of cell binding, which enables
fabrication of cellular arrays with higher pattern fidelity.
Finally, Chapter 5 demonstrates an application of T cell arrays as a living cell-based
immunological sensor. The Ca2+ level of T cells exhibits a strong correlation with the amount of
peptide analytes added to the system. The average dose-response behavior verifies that the
living cell array system can be used as a sensor. The results of individual cell responses reveal
that the cellular array system also has potentials in high throughput single cell assay applications.
6.2 Directions for future investigations
The living cell-based immunological sensor tested in this work is based on the 5C.C7 T cell
blast activation by MCC peptides, which has been well characterized by many researchers.
'While this system works well to prove the feasibility of living cell-based devices, there are
several aspects of this concept that can be further investigated. Real infections come in a form of
an intact microbe, not processed peptides. Thus, it will be closer to a realistic application if
proper cell lines are used to detect a whole virus or bacterium.
However, time: delays involved in processing whole microbes by antigen presenting cells are
not negligible, even if not exactly known yet. Considering overnight incubation of antigen
presenting cells with target proteins is a commonly accepted approach for T cell activation study,
it is not very likely that living cell systems are eligible for early detection applications.
Furthermore, kinetics in antigen processing and presentation is not known to the community and
suggests more complications in quantitative analysis.
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This point makes single cell assay applications using cellular arrays more interesting. For
example, the sensor system can be used to study kinetics of antigen processing and presentation,
instead of dose-response behavior of T cells. As kinetics of T cell Ca2+ signaling is, or can be
known from the same kind of experiments as performed in this project, kinetics involved in
antigen processing and presentation can be resolved from kinetic characteristics of the entire
events.
Single cell arrays allow new possibilities in controlling cell-cell interactions. Unlike in
random co-culture approaches, a great number of one-on-one pairs of two different cells can be
brought into contact simultaneously by sandwiching two cellular arrays together. The controlled
cell-cell interactions will help to speed up the data gaining and analysis processes. For example,
this setup can eliminate the peptide diffusion time delays discussed in Chapter 5, and provide
abundant data for Ca2+ oscillation frequency, TCR / peptide-MHC engagement kinetics, etc.
If combined with a microfluidic system, cellular arrays can be utilized in a high throughput
combinatorial study based on single cells. Currently, 96- (or 154-) well culture plates are used
for automated bulk assays with 96 different recipes of reagents. In a microfluidic system, two
reagent solutions can flow in a biaxial concentration-gradient pattern across a cellular array
platform, where each cell can be cultured under a different concentration recipe. Mapping cell
responses according to various reagent recipes will reveal a great deal of information from a
single experiment.
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Appendices
A1. Flow chamber
PDMS preparation
The curing agent of Sylgard® 184 was added at a 1 to 10 ratio to the silicone elastomer base.
The mixture was well stirred with a stick and then aspirated in a desiccator until air bubbles
trapped during stirring disappear entirely. Degassed PDMS mixture was poured into molds.
Flow chamber system
A mold for a flow chamber was cut out of aluminum block into the shape shown in Figure A1.1.
The silicone tubing was snugged into the stubs at both ends of the aluminum mold. The mold
with tubing was placed between two glass slides and clamped with paper clips together with a
dish made by folding aluminum foil. PDMS was poured gently into the gap of two glass slide
with the caution not to entrap air bubbles. Trapped air bubbles could be removed by suction with
a glass pipet. PDMS was cured overnight on top of the hot oven (not inside the oven). After
removing glass slides, the aluminum mold was taken out carefully with slight stretch of PDMS.
Figure A1.2 shows brief procedures to make a PDMS chamber.
A whole flow chamber was assembled with the PDMS chamber, an upper plate, and a lower
patterned substrate used as a cellular array template. The whole flow chamber assembly setups
were shown in Figure A1.3. These components were clamped together between metal frames
with bolts. The upper plate was made of transparent polycarbonate and has a 1 cm diameter hole
at the center. The hole was used to add cells, MCC peptides, or other reagents. When the flow
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chamber system should be purged with medium, the hole was covered with PDMS sheet that is
slightly thicker than the upper metal frame, so that it gives tight seal when another polycarbonate
plate was placed atop and tightened to the upper metal frame with nuts. Alternatively, a tightly
fitting plug was tried for sealing, but when unplugged, it generated a negative pressure in the
chamber, which agitated cells on an array. Contrarily, the PDMS sheet covering the hole could
be removed easily without causing the problem. During the imaging experiments, the hole was
again exposed to air supply in the environmental chamber.
A peristaltic pump was used to purge the medium into the flow chamber. The inlet was made
near the bottom of the flow chamber and the outlet near the top to generate a slight upward
stream of medium that is desirable for lifting unbound extra cells off the surface. Turbulent flow
at high flow rate helped eliminate weakly bound extra cells without removing patterned cells.
When the flow chamber assembly was turned upside down to take extra cells off, air bubble
trapped inside the flow chamber would wipe out even patterned cells on arrays made with
antibody array templates. However, in hydrogel microwell system, air bubble only affected
loosely bound extra cells and patterned cells inside microwells survived the stroke of air bubble.
Thus, air bubbles were intentionally introduced in the flow chamber and utilized to wipe out
extra cells.
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Figure A1.1. Design of aluminum mold for PDMS flow chamber casting.
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IFigure A1.2. Procedures to cast a PDMS flow chamber; 1. plug tubing. 2. clamp with glass
slides and an aluminum foil dish. 3. pour and cure PDMS. 4. remove glass slides and
a dish. 5. tilt and take out the aluminum part with slight stretch of cured PDMS. 6.
trim edges of a PDMS flow chamber.
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A2. Living cell-based immunological sensor using B cell
array fabricated on graft-copolymer patterned templates
,RPMI media preparation
]RPMI 1640 medium was prepared with the addition of 10 % fetal calf serum (FCS), 50 [pM 13-
mercaptoethanol, 2 mM L-Glut, 100 U/mL penicillin, 100 [Ig/mL streptomycin. Phenol-
deficient RPMI 1640 was used for microscope imaging experiments to reduce the
autofluorescence.
TFura-2 dye loading into T cells
A stock solution of the dye was prepared in dry DMSO at the concentration of 1 [tg/gL and
stored at -20 °C until the later use. It was thawed at room temperature before use. To remove
debris or dead APCs, T cells were ficolled and about 105 T cells were re-suspended in 100 L
the imaging media. T cell suspension was added with 2 tL of the dye stock solution and
incubated for 20 minutes at 37 °C. T cells were palletized and re-suspended in the fresh imaging
media.
Pulsing B cells with MCC peptide
13 cells were pulsed with a given amount of MCC peptides in RPMI medium and incubated for
an hour at 37 °C.
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Aicroscopy for Tr and B cell interaction
About 105 fura-2 loaded T cells were added onto a B cell array that had previously been pulsed
with a given amount of MCC peptides. Fluorescent intensities from the dye were measured at
the excitation wavelengths of 340 nm and 380 nm, respectively. After corrections for
background noise level, the ratio of the intensity from 340 nm excitation to the intensity from
380 nm excitation was taken to represent the T cell activity level. This ratio value was mapped
onto a grey scale of 0 for minimum to 255 for maximum to visualize the value.
Results and discussions
The concept of a living cell-based immune sensor was tested with use of B cell arrays. Although
it was not the most effective approach to achieve high pattern fidelity, non-biotinylated B cells
were used for cellular array fabrication to rule out complications related to the possible
modification of MHC molecules on B cell membrane during the biotinylation. Biotin-
streptavidin mediated antibody array templates (approach II in chapter 3) were employed for the
study.
Typically, responses of T cells on an array of B cells with MCC peptides vary for each T cell in
the aspects of the engagement timing and the level of activity induced by the interaction with B
cells. Figure A2.1 presents fura ratio intensities of several T cells on a B cell array pulsed with
0.05 tiM MCC peptides. Each T cell shown in Figure A2.1 has different peak height, width, and
tirning. Also, not all T cells do have a higher activity level when interacting with a B cell array
pulsed with higher MCC peptide concentration. In Figure A2.2 were shown the fura ratio
intensities for a randomly selected T cell for varying peptide pulsing concentrations. Stochastic
127
properties of T cell activation make it difficult to compare activation level of a T cell directly
with another.
However, the increasing trend of T cell activity with peptide pulsing concentration can be drawn
by considering the average of T cell responses for given peptide pulsing concentrations. For the
purpose, the area under the fura ratio intensity curve was taken for each T cell, and the average
was taken from all T cells interacting with B cells, and plotted in Figure A2.3. The baseline
value of the plot represents the curve area for non-activated T cell.
Considering the range of data distribution around the average value, a larger sample group would
have been helpful to draw conclusions that were statistically more meaningful. However, it was
difficult to realize because of the following reasons; although the same number of T cells was
added for each peptide pulsing concentration, it was not possible to achieve uniform distribution
of T cells across B cell arrays and the population of T cells within the microscopy window varied
over samples. In addition, as T cells have motility, some T cells crawled up on B cells, which
obscured the signal from the dye with the T cells staying out of focus. Some T cells formed
clumps at higher seeding density. The clumps gave out strong intensity of signal, which made
correct analysis difficult. For further investigation to prove the concept of living cell-based
immune sensor, it is highly desirable to have uniformly distributed T cells interacting with B
cells in a large number.
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Figure A2.1. Responses of T cells interacting with B cells that had been pulsed with 0.05 M
peptides.
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T cell responses at various peptide doses
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Figure A2.2. Response of an arbitrarily selected T cell for each peptide dose.
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Figure A2.3. Average T cell responses at different dose conditions.
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Figure A3.2. Comparison of average intensities of each batch at different doses.
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